Board of Directors Policy Manual November 2013

Transcription

Board of Directors
Policy Manual
November 2013
TABLE OF CONTENTS
Preamble
Part I:
Strategic Direction
I-1
Strategic Planning
I-2
Community Engagement
Part II:
Excellent Management
II-1
CEO Selection and Succession Planning
II-2
CEO Direction
II-3
CEO Position Description
II-4
CEO Performance Management and Evaluation
II-5
CEO Compensation
II-6
CEO Expense Reimbursement and Travel Policy
II-7
Occupational Health and Safety – Accountability Framework
II-8
Chief of Staff Selection and Succession Planning
II-9
Chief of Staff Direction
II-10
Chief of Staff Position Description
II-11
Chief of Staff Performance Management and Evaluation
II-12
Chief of Staff Compensation
II-13
Reporting on Compliance
II-14
Whistleblowing
Part III:
Program Quality and Effectiveness
III-1
Quality Improvement and Safety
III-2
Risk Management
III-3
Ethics Framework
III-4
Respect for Diversity
III-5
Privacy, Security and Confidentiality of Information
III-6
Access to Information
III-7
Complaints (Patient Care and Other)
III-8
Research
III-9
Research Ethics Board Appeals
Part IV:
Financial and Organizational Viability
IV-1
Financial Objectives
IV-2
Financial Planning and Performance
IV-3
Asset Protection
IV-4
Delegation of Signing Authority
IV-5
Borrowing
IV-6
Investment Policy
IV-7
Environmental Protection
Part V:
Board Effectiveness
1. Governance Policy Framework
V-A-1
Principles of Governance and Board Accountability
V-A-2
Roles and Responsibilities of the Board of Directors
V-A-3
Responsibilities as an Elected and Ex-Officio Director
V-A-4
Director’s Declaration
V-A-5
Guidelines for the Selection of Directors
V-A-6
Board Size and Composition
V-A-7
Board Standing Committee Principles
V-A-8
Position Description for the Chair
V-A-9
Position Description for the Vice-Chair
V-A-10
Position Description for the Treasurer
V-A-11
Position Description for the Secretary
V-A-12
Position Description for a Board Committee Chair
V-A-13
Conflict of Interest
2. Governance Process
V-B-1
Nomination Process for the Board of Directors
V-B-2
Nominations Process for Board Officers
V-B-3
Nominations Process for the Chair, Directors and Non-Director
Members of Board Standing and Special Committees
V-B-4
Ongoing Board Education
V-B-5
Board Goals and Board Work Plan
V-B-6
Board Meetings
V-B-7
Board and Individual Director Evaluation
V-B-8
Receipt of Gifts by Individual Directors
V-B-9
Board Member Recognition
V-B-10
Reimbursement of Director Expenses
V-B-11
Resignation and/or Removal of a Director
V-B-12
Review of Board Policies
Part VI:
External Relationships
VI-1
Communications
VI-2
Contributions
PREAMBLE
Purpose:
This Board Policy Manual provides the foundation for implementing effective
governance of the Corporation. The Board has adopted the “Pointer-Orlikoff”
governance model, which includes three roles for the Board: policy-formulation,
decision-making and oversight.
“Board policies perform two absolutely essential functions. First, they express Board
expectations – of the organization as a whole, of itself, of management and the medical
staff. Policies are the means by which Boards specify and convey what they want done
(and what they want the organization to refrain from doing) in addition to the range of
acceptable (and unacceptable) means for accomplishing specified goals. To lead rather
than follow, policies must clarify and articulate Board expectations. Second, policy is
the mechanism by which Boards direct and constrain as they delegate authority and
tasks to management and the medical staff.”1
Scope and Organization of Policies:
Many boards establish policies related only to their own structures and processes (i.e.
those matters that are contained in Part V of the Board Policy Manual). However, a
critical element of the “Pointer-Orlikoff” governance model is for the Board to establish
policies related to each of its defined areas of responsibility. Consequently, the Board
policies are organized according to the Board responsibilities as described in Policy VA-2:
• Strategic Direction
• Excellent Management
• Program Quality and Effectiveness
• Financial and Organizational Viability
• Board Effectiveness
• External Relationships
These policies then provide the context for the Board to fulfill its two other roles:
decision-making and oversight in relation to each of its six areas of responsibility.
1 Pointer and Orlikoff, Board Work: Governing Health Care Organizations, San Francisco: Jossey Bass, 1999.
Review of Policies:
It is anticipated that, over time, the Corporation will amend these Board policies and
develop new ones to respond to changing circumstances. A policy guiding the process
to review these Board policies is included in this Board Policy Manual (Policy V-B-13).
Definitions:
In this Board Policy Manual:
“Board” means the board of directors of the Corporation;
“Board Policy Manual” means the written policies and procedures adopted by the
Board concerning Board governance of the Corporation in accordance with Section 16.2
of the Corporate By-law, as amended from time to time;
“Chair” means the chair of the Board;
“Chief Executive Officer” means, in addition to ‘administrator’ as defined in the Public
Hospitals Act, the President and Chief Executive Officer of the Corporation;
“Chief Nursing Executive” means the senior nurse employed by the Corporation, who
reports directly to the Chief Executive Officer and is responsible for nursing services
provided in the Hospital;
“Chief of Staff” means the Medical Staff member appointed by the Board, in
accordance with the Professional Staff By-law, to serve as Chief of Staff in accordance
with the regulations under the Public Hospitals Act;
“Corporation” means The Credit Valley Hospital and Trillium Health Centre;
“Dental Staff” means those Dentists and Oral and Maxillofacial Surgeons appointed by
the Board to attend or perform dental services or oral and maxillofacial surgery, as
applicable, for patients in the Hospital;
“Dentist” means a dental practitioner in good standing with the Royal College of Dental
Surgeons of Ontario;
“Director” means a member of the Board;
“Ex-officio” means membership “by virtue of office” and includes all rights,
responsibilities and power to vote unless otherwise specified;
“Extended Class Nursing Staff” means those Registered Nurses in the Extended
Class who are:
(a)
employed by the Corporation and who are authorized to diagnose,
prescribe for or treat patients in the Hospital; and
(b)
not employed by the Corporation and to whom the Board has granted
privileges to diagnose, prescribe for or treat patients in the Hospital;
“Hospital” means the public hospital or hospitals operated by the Corporation;
“LHIN” means the Mississauga Halton Local Health Integration Network;
“Medical Advisory Committee” means the committee established by the Board
pursuant to the Professional Staff By-law as required by the Public Hospitals Act;
“Medical Staff” means those Physicians who are appointed by the Board and who are
granted privileges to practice medicine in the Hospital;
“Members” means members of the Corporation as described in Article 2 of the
Corporate By-law;
“Midwife” means a midwife in good standing with the College of Midwives of Ontario;
“Midwifery Staff” means those Midwives who are appointed by the Board and granted
privileges to practice midwifery in the Hospital;
“Ministry” means the Ministry of Health and Long-Term Care;
“Oral and Maxillofacial Surgeons” means those dentists in good standing who hold a
specialty certificate from the Royal College of Dental Surgeons of Ontario authorizing
practice in oral and maxillofacial surgery;
“Physician” means a medical practitioner in good standing with the College of
Physicians and Surgeons of Ontario;
“Professional Staff” means the Medical Staff, Dental Staff, Midwifery Staff and
members of the Extended Class Nursing Staff who are not employees of the
Corporation;
“Public Hospitals Act” means the Public Hospitals Act (Ontario), and, where the
context requires, includes the regulations made thereunder;
“Registered Nurse in the Extended Class” means a member in good standing with
the College of Nurses of Ontario who is a registered nurse and who holds an extended
certificate of registration under the Nursing Act, 1991; and
“Rules” means the rules adopted by the Board in accordance with Section 16.2 of the
Corporate By-law
Part I:
Strategic Direction
CATEGORY:
STRATEGIC DIRECTION
POLICY #:
I-1
SUBJECT:
STRATEGIC PLANNING
Strategic planning is a systematic process for assessing a changing environment
and creating a plan of action that will position the Corporation to be successful in
the environment consistent with its vision, mission and core values. As per Policy
V-A-2, the Board, in collaboration with the CEO, Chief of Staff and the senior
management team, is responsible to establish the Corporation’s strategic
directions consistent with the planning cycle, the Strategic Plan and the
Corporation’s vision, mission and core values. The vision, mission and core
values of the Corporation provide the foundation upon which the strategic
directions are developed.
The strategic plan will incorporate specific, focused and measurable strategic
directions to be pursued over the course of the plan, as well as longer term
directional priorities.
The Board will:
• consider key stakeholders and health care needs and ensure appropriate
engagement with the community, the LHIN and other health service providers
when developing plans and setting priorities for the delivery of hospital-based
health care as required under the Local Health System Integration Act, 2006;
• establish and periodically review and update the Corporation’s vision, mission
and core values;
• contribute to the development of and approve the Corporation’s strategic plan,
ensuring that it is aligned with community needs, Ministry policy and the LHIN
integrated health services plan.
• conduct a review of the strategic plan, as part of a regular annual planning
cycle, and assess the need to refine the strategic directions as the
environment dictates;
• approve the measures and targets related to each strategic direction and
direct management to report on a regular basis the progress that is being
made consistent with the strategic directions and the overall plan;
• in approving the annual hospital operating plan, ensure that the operating plan
enables the attainment of the strategic plan and directions over time; and
• monitor and measure corporate performance regularly consistent with the
Board-approved strategic and operating plans and performance targets and
performance metrics.
Strategic Planning Process
1. The CEO is responsible to the Board for establishing the strategic planning
process, for Board approval. The Board will engage with the CEO and senior
management team in developing the strategic plan and monitoring it on an
on-going basis. The Governance Committee will provide guidance to
management and support the Board in preparation for the initial development
and periodic monitoring of the corporate strategic plan.
2. Once the strategic plan has been developed, everything the Corporation
currently does, undertakes as new, or stops doing, will be measured to
assess whether or not it advances the achievement of the strategic plan.
3. The Corporation’s annual operating plan will ensure the advancement of the
strategic plan by addressing annual corporate goals and objectives. The
annual corporate goals and objectives will be set by the CEO with Board
approval.
4. Annually, the Board will review the corporate goals and objectives prepared
by the CEO.
5. Annually, the Board will establish Board goals consistent with the vision,
mission and core values and the strategic plan, and key issues that are a
priority for the Board in the coming year.
6. At its annual retreat, the Board will review the strategic plan and the progress
being made to advance its achievement. As necessary, the Board will direct
the CEO and senior management team to augment/revise/update the
strategic plan to ensure it continues to support the achievement of the
Corporation’s vision, mission and core values.
7. The CEO and senior management team will provide regular monitoring and
progress reports to the Board according to the Board’s work plan.
Page 2 of 2
CATEGORY:
STRATEGIC DIRECTION
POLICY #:
I-2
SUBJECT:
COMMUNITY ENGAGEMENT
Section 16(6) of the Local Health System Integration Act, 2006 requires all health
service providers to engage the communities served in planning and setting
priorities.
The Board will ensure that processes are established as required for
engagement with the LHINs, other health service providers and the community
when developing plans and setting priorities. It is essential that the Corporation
communicate regularly to the broader public about its operations and future
directions. The process and scope for community engagement will vary
depending on the issue and will be approved by the Board, upon the
recommendation of the CEO as required.
It will be essential for the Corporation to maintain strong and positive
relationships, which have been established by The Credit Valley Hospital and
Trillium Health Centre with Regional Municipality of Peel, the City of Toronto and
the City of Mississauga. Mechanisms for nurturing these relationships may
include: the Chair and CEO to meet at least annually with regional and municipal
councils to present and engage in dialogue on strategic directions, priorities and
challenges.
Recognizing the breadth of the community, the Chair and the CEO will ensure
that information on the Corporation’s activities is widely communicated to the
public through the media throughout the catchment area. The Board will be
sensitive to the needs and diversity of the community.
Board mechanisms for community engagement may include but are not limited
to:
• initiation of Community Advisory Committees/Panels;
• posting on the Corporation’s website highlights of Board meetings;
• periodic articles in the local media on matters of interest to the community by
the Corporation;
• annual meeting of the Chair and CEO with the regional and area municipal
councils to present on the Corporation’s strategic plan, priorities, and
challenges; and
• program or issue specific processes for community engagement as may be
approved by the Board, upon the recommendation of the CEO, from time to
time.
Page 2 of 2
Part II:
Excellent
Management
CATEGORY:
EXCELLENT MANAGEMENT
POLICY #:
II-1
SUBJECT:
CEO SELECTION AND SUCCESSION PLANNING
The Board will ensure that provision is made for continuity of leadership for the
Corporation. The Board will have in place a documented process for succession should
the CEO position become vacant due to sudden vacancy (e.g. death, resignation or
termination) or planned vacancy (e.g. retirement). The succession plan will also specify
the process for appointing an interim CEO, should the CEO require an extended leave of
absence due to personal, health or other reasons. The CEO will report on the
succession plan annually during the CEO evaluation process.
1. Planned Vacancy (e.g. retirement)
The process to fill a planned vacancy will be as follows:
i)
The Board will establish a CEO Search Committee consisting of up to four
elected Directors, including the Chair, the Chief of Staff and the President of
the Professional Staff. Support for the CEO Search Committee will be
provided by the Vice President, Human Resources and Organizational
Development i unless directed differently by the Chair.
ii)
The CEO Search Committee will be chaired by the Chair or his/her delegate.
iii)
The CEO Search Committee may, at its discretion, select a search firm to
assist with the process.
iv)
The CEO Search Committee will interview a short list of candidates and
recommend to the Board its candidate of choice.
3. Sudden Vacancy (e.g. death, resignation, termination, extended leave)
The CEO will identify to the Human Resources Committee in writing at the beginning of
each fiscal year which member(s) of the senior management team are recommended to
fill the role of interim CEO, if a sudden vacancy occurs. The appointment of an interim
CEO will be subject to Board approval.
An offer will be subject to submission of a declaration that the candidate has no conflict
of interest consistent with organizational policy, in a form as required by the Board, and
satisfactory results of a criminal reference check as determined in the sole discretion of
the Board.
A legally binding employment agreement will be developed by an employment lawyer
and will be executed by the Chair and the candidate accepting the position of CEO.
Page 2 of 2
CATEGORY:
POLICY #:
II-2
SUBJECT:
CEO DIRECTION
The Board’s sole official connection to the Corporation, its achievements and conduct
will be through the CEO. The CEO is appointed by, reports to, and is accountable to the
Board.
The Board provides direction to the CEO in accordance with Board policies. The Board
delegates responsibility and authority to the CEO for the management and operation of
the Corporation and requires accountability to the Board.
The CEO is required to follow directions of the Board as received through the Chair.
When Directors or committee members make requests without Board authorization, the
CEO can decline such requests when in the CEO’s opinion a material amount of staff
time or funds are required to carry out the requests. The CEO may refer the matter
through the Chair to the next Board meeting for discussion.
The CEO shall perform the duties described in Policy II-3 (CEO Position Description) as
set out in the Board Policy Manual.
The CEO will report, and be responsible, to the Board for implementing the
Corporation’s strategic plan, operating and capital plan, and for the day-to-day operation
of the facilities of the Corporation in a manner consistent with Board policies.
The CEO will not cause or, with the CEO’s knowledge, allow any practice, activity,
decision or organizational circumstance that is either unlawful, imprudent, or in violation
of commonly accepted business and professional ethics.
CATEGORY:
POLICY #:
II-3
SUBJECT:
PRESIDENT and CHIEF EXECUTIVE OFFICER
POSITION DESCRIPTION
The President and Chief Executive Officer (‘the CEO’) of Trillium Health Partners is
appointed by, and is directly accountable to the Board of Directors (‘the Board’),
reporting through the Chair, for ensuring the organization functions within the framework
of the strategic plan and policies established by the Board of Directors.
The CEO will have overall responsibility for the operations and administration of the
organization.
The CEO will attend to both the internal and external dimensions of the role, by
discharging the following responsibilities:
Internal Organization Environment:
1. Provide clear and decisive leadership
2. Create the necessary structures, processes, and systems that will result in the
best possible clinical outcomes and patient experiences
3. Ensure the resources of the organization (financial, human, and capital assets)
are aligned and managed in keeping with the strategic plan
4. Instill and cultivate a spirit of research, innovation and education
5. Continue to build a fair and equitable workplace including strong relationships
with physicians
6. Ensure compliance with all applicable legislative requirements
7. Lend strong support to the Foundations
External Health Care System Environment:
1. Champion health system partnerships and linkages with the community and
other health care providers locally and provincially
2. Forge and sustain relationships at both the municipal and provincial government
levels
3. Facilitate a mutually beneficial relationship with the University of Toronto,
Mississauga Academy of Medicine that is supportive of teaching excellence
The following leadership competencies are required in this position:
Creating Vision and Leading Change
• Creates, and is able to execute, on a vision.
•
Success in working with broad constituent groups to achieve innovation and
transformational change in complex health care environments.
•
Models the behaviour and demonstrates understanding of the requisite
leadership skills required to lead leaders through continuous transformation and
change.
Influence
• Ability to inspire enthusiasm, broad commitment and organizational capability for
the vision and shared mission and purpose.
•
The courage, curiosity and intellectual capacity to identify bold solutions to
complex problems and is able to capitalize upon new ideas, tools and
technology.
•
Ability to build exceptional relationships with diverse external partners and
stakeholders.
Leading Others
• Outstanding communications ability.
•
High capacity for developing respectful and supportive interpersonal
relationships.
•
Commitment to quality and embraces best practices in all activities.
•
Supports, coaches and mentors others, particularly members of the senior
management team, in achieving their personal best.
•
Leads by example within the organization and demonstrates accountability for
her/his personal behaviours and practices.
Results Driven
• Identifies tangible goals as part of the solution to complex problems and
demonstrates leadership in achieving these objectives.
•
The ability to develop, lead and sustain a culture that values innovation, learning,
teaching, research, and a highly collaborative integrative and efficient approach
to achieve the best patient outcomes.
Sound Judgement
• The ability to balance risks with knowledge, wisdom, and intellectual capacity,
and bases all decisions on the well-being of patients and families, fiscally sound
practices and the vision and goals of the organization.
CATEGORY:
POLICY #:
II-4
SUBJECT:
CEO PERFORMANCE MANAGEMENT AND EVALUATION
The Board is responsible for appointing the CEO as well as managing and evaluating
their performance. Performance evaluation of the CEO is the process of reviewing and
evaluating his/her performance based on progress towards achieving-mutually agreed
objectives.. A formal performance appraisal provides for regular review and assessment
and an opportunity for the Board to discuss expectations with the CEO. It also allows the
opportunity for discussion of core competencies and personal development goals.
Upon the recommendation of the Chair, the Board will establish measurable annual
performance objectives in cooperation with the CEO, assess CEO performance
annually, and determine CEO compensation.
The performance review process provides an opportunity to recognize the CEO’s level of
performance, to collaboratively develop the Corporation’s priorities for the next fiscal
year to present to the Board for approval, and to plan strategies to support the CEO and
the Corporation’s operations as articulated in its operational plan.
Guiding Principles:
i)
Performance management supports, reinforces and integrates the
achievement of strategic and business plan results with individual
performance goals.
ii)
Performance objectives, measures and indicators will be established.
Performance commitments and measures will be set at a level that reflects the
high level of performance expected.
iii)
Performance management focuses both on improving organizational
performance, processes and structure and on enhancing the CEO’s
performance.
iv)
The operational plan should include reference to the CEO’s expectations for
senior management team members, thereby promoting a consistent and
continuous approach to performance measurement across the senior
management team.
Process:
1. The CEO will develop annual performance objectives in consultation with the
Chair, for initial discussion with the Human Resources Committee, which will
then recommend the performance objectives to the Board for approval each
March/April.
2. The CEO performance review process will be the responsibility of the Chair and
the Chair of the Human Resources Committee, in consultation with the CEO. The
review process will commence annually in the month of October (mid-year
review) and March/April (year-end review).
3. The Chair and Chair, Human Resources Committee will review the CEO’s
performance against the objectives on a semi-annual basis and will report the
outcome of the review to the Board in an in camera session.
4. Feedback will be gathered from all Directors annually on the performance of the
CEO and such feedback will be documented in writing. The Chair and Chair,
Human Resources Committee will then compile the feedback and develop the
performance review documentation.
5. The Chair and Chair, Human Resources Committee will provide a report to the
Board, in an in camera session, on the CEO’s performance relative to both
achievement of the goals and the assessment of core competencies.
6. The Chair will communicate the results of the evaluation to the CEO.
Page 2 of 2
CATEGORY:
POLICY #:
II-5
SUBJECT:
CEO COMPENSATION
The Board is responsible for establishing an appropriate and competitive compensation
package for the position of CEO in order to:
i)
attract and retain a highly skilled CEO with the requisite competencies; and
ii)
reward meritorious performance.
The compensation package paid to the CEO will be set out in a properly prepared
Board-approved employment contract between the Corporation and the CEO.
In establishing the compensation package, consideration will be given to market rates
paid for similar positions within the local geographic area and within the Province,
particularly as applicable to public sector employment. The total compensation package
for the CEO will include the sum of base salary, vacation 1 incentive compensation,
benefits, and perquisites allowable according to Broader Public Sector directives and
guidelines. In keeping with all applicable legislation CEO compensation will be linked to
achieving performance improvement targets set out in the annual quality improvement
plan.
Adjustments to the compensation package will be considered on a regular basis, giving
consideration to cost of living changes, market rates, and changes in duties or
requirements. Changes to the compensation package will only be made upon Board
approval, and will generally be made at the time of the annual reviews. Determination
and payout of incentive compensation will be made once all the applicable information is
available. Upon the recommendation of the Board Chair and Chair of the Human
Resources Committee, the Board will approve the incentive compensation calculation.
The Board Chair and Chair of the Human Resources Committee, will annually review the
CEO compensation for possible annual adjustments, subject to the CEO meeting
performance expectations as determined through the performance review process, and
within the limits of the overall salary budget set by the Board.
1
,In keeping with all relevant legislation.
CATEGORY:
POLICY #:
II-6
SUBJECT:
CEO EXPENSE REIMBURSEMENT AND TRAVEL POLICY
Consistent with applicable legislation, the CEO will be reimbursed for reasonable
expenses incurred, in compliance with the expense claim directives issued by the
Management Board of Cabinet under the Broader Public Sector Accountability Act,
2010, while carrying out duties and traveling for the Corporation. All out of country travel,
paid for by the corporation, is to be approved in writing by the Chair prior to any trip
taking place.
CEO reimbursement expenses should be consistent with the expense and travel policies
and practices for other employees of the Corporation; exception may be permitted at the
discretion of the Chair.
The Chair, in consultation with the Vice President, Finance and Risk, Chief Financial
Officer, will approve allowable expenses and travel claims.
CEO expenses will be made public in keeping with the requirements under the Broader
Public Sector Accountability Act, 2010.
CATEGORY:
POLICY #:
II-7
SUBJECT:
OCCUPATIONAL HEALTH AND SAFETY – ACCOUNTABILITY
FRAMEWORK
The Corporation, the Board and CEO are committed to the health, safety and wellness
of employees, and the prevention of occupational injuries and disease in support of a
safe and healthy workplace. The Corporation acknowledges its responsibility to
effectively manage and communicate its programs regarding health, safety and wellness
and to maintain compliance with the Occupational Health and Safety Act and related
regulations. Every employee, including those with privileges, contractors, students and
volunteers are responsible for working in a safe and healthy manner and promoting a
secure and hazard free environment.
In accordance with the Corporate By-law (Section 15.6), there will be an occupational
health and safety program for the Corporation, which includes procedures for:
i)
a safe and healthy work environment in the Corporation;
ii)
the safe use of substances, equipment and medical devices in the
Corporation;
iii)
safe and healthy work practices in the Corporation;
iv)
the prevention of accidents to persons on the premises of the Corporation;
and the elimination of undue risks and the minimizing of hazards inherent in
the Corporation environment; and
v)
The CEO to designate an individual to be in charge of occupational health and
safety in the Corporation. The designate will be responsible to the CEO for the
implementation of the Occupational Health and Safety Program.
The CEO will report to the Board as necessary on matters concerning the Occupational
Health and Safety Program.
The Board will receive annual reports from the CEO on the Corporation’s Occupational
Health and Safety Program to include information about the ability of the Corporation to
meet occupational health and safety requirements, identification of risk issues, statistical
data on incidents, and program outcomes. All members of the organization are expected
to demonstrate their commitment towards a safe and healthy environment by acting in
compliance with this Policy.
CATEGORY:
POLICY #:
II-8
SUBJECT:
CHIEF OF STAFF SELECTION AND SUCCESSION PLANNING
The Board will ensure that provision is made for continuity of leadership for the
Corporation. The Board will have in place a documented process for succession
should the Chief of Staff position become vacant due to sudden vacancy (e.g.
death, resignation or termination) or planned vacancy (e.g. retirement). The
succession plan will also specify the process for appointing an interim Chief of
Staff, should the Chief of Staff require an extended leave of absence due to
personal, health or other reasons.
The Board will select and appoint the Chief of Staff and will provide for Chief of
Staff succession planning.
Based on best practice, the Chief of Staff is expected to identify and develop
his/her successor through internal succession planning. The Chief of Staff will
report on this matter annually during the Chief of Staff evaluation process.
1. Sudden Vacancy (e.g. death, resignation, termination, extended leave)
The Chief of Staff shall, in consultation with the CEO, designate an alternate to
act during the absence of the Chief of Staff. If the Chief of Staff is not able to
designate an alternate due to death, termination or other circumstance, the CEO
and Chair of the Board of Directors, in consultation with Medical Advisory
Committee (MAC) will appoint an alternate for an interim period. The
appointment of an interim Chief of Staff will be subject to Board approval.
2. Planned Vacancy (e.g. retirement)
i)
In accordance with the Professional Staff By-law (Section 9.2), the
Board shall appoint a Physician on the Active Staff to be the Chief of
Staff after considering the recommendations of a selection committee
composed of members of the Board and the Medical Advisory
Committee.
ii)
Membership of the Selection Committee shall include: the Chair who
shall be chair; three members of the Medical Advisory Committee, one
of whom will be the President of the Professional Staff or his/her
delegate from the Professional Staff executive; the Chief Nursing
Executive; the CEO; one other member of the active Professional Staff
as the Chair deems advisable; and other Directors as the Chair deems
advisable.
iii)
The Selection Committee may, at its discretion, select a search firm to
assist with the process.
iv)
The Selection Committee will interview a short list of candidates and
recommend to the Board its candidate of choice.
v)
Subject to annual confirmation by the Board, an appointment of the
Chief of Staff shall be for a term of five years; however, the Chief of
Staff shall hold office until a successor is appointed.
vi)
In accordance with Section 9.3(c) of the Professional Staff By-law, the
maximum number of years in this office shall be ten provided, however,
that following a break in the continuous service of at least one-year, the
same person may be reappointed.
vii)
The Board at any time may revoke or suspend the appointment of the
Chief of Staff.
If a new Chief of Staff has not been appointed before the departure of the current
Chief of Staff, the current Chief of Staff may hold office until a successor is
appointed or an interim appointment may be made at the discretion of the Board.
Page 2 of 2
CATEGORY:
POLICY #:
II-9
SUBJECT:
CHIEF OF STAFF DIRECTION
The Board provides direction to the Chief of Staff (CoS) in accordance with Board
policies. The Board delegates responsibility and authority to the Chief of Staff for the
general clinical organization of the Corporation and the supervision and practice of
credentialed professional staff in the Corporation.
In accordance with the Professional Staff By-law (Section 9.3), the Chief of Staff shall:
a) be an ex-officio member of the Board and, as a director, fulfill fiduciary duties to
the Corporation;
b) chair the Medical Advisory Committee;
c) be an ex-officio member of all Medical Advisory Committee sub-committees;
d) comply with the Professional Staff By-law, the Rules and Regulations and
Policies (as defined in the Professional Staff By-law), and the Professional Staff
Credentialing Policy and Professional Staff Credentialing Procedure;
e) be accountable to the Board for all the care provided by Professional Staff
members to patients of the Hospital;
f)
perform the duties described in Policy II-10 (Chief of Staff Position Description)
as set out in the Board Policy Manual; and
g) perform such other duties as directed by the Board from time to time.
CATEGORY:
POLICY #:
II-10
SUBJECT:
CHIEF OF STAFF POSITION DESCRIPTION
The Chief of Staff (COS) is responsible directly to the Board of Directors, reporting through the
Chair, for ensuring that the medical staff organization functions within the framework of the
policies established by the Board of Directors.
The Chief of Staff, in addition to being the Chair of the Medical Advisory Committee, will have
overall responsibility for:
• physician accountability, engagement, performance and discipline*
• medical administration**
• medical research**
• academic affairs***
* Reporting to the Chair of the Board and the Board
** Reporting to the CEO
*** Reporting to the CEO and Medical Academy
LIST THE SPECIFIC DUTIES OR RESPONSIBILITIES:
Administrative Duties of the Chief of Staff:
(a)
report regularly in writing including the minutes of the Medical Advisory Committee to
the Board about the activities, recommendations and actions of the Medical Advisory
Committee and any other matters about which they should have knowledge;
(b)
be an ex-officio member of all committees that report to the Medical Advisory
Committee and exercise leadership in the selection of appointments to and the
functioning of the committees of the Medical Advisory Committee;
(c)
act on other committees as requested by the Board of Governors;
(d)
participate in the corporation’s administrative team for the purpose of providing input
into formulating and evaluating policies, priorities, allocation of resources and
general management strategies;
(e)
ensure his/her duties are assumed by a departmental chief when absent from the
hospital;
(f)
(g)
ensure, with the chief executive officer:
i.
the promotion, establishment and maintenance of cooperative relations
between the employees, patients, visitors, physicians, midwives and
administration;
ii.
that the standards of the Canadian Council of Health Services Accreditation
are reviewed and implemented;
iii.
the overall direction and management of medical research and academic
affairs;
iv.
the co-ordination of future planning and development of the hospital is
consistent with the hospital’s strategic plan;
Be a member of the Senior Management Team of the hospital.
Medical Supervisory Duties of the Chief of Staff:
a)
be responsible to the Board for the credentialed professional staff organization of the
hospital and for the supervision of the credentialed professional staff care given to all
patients of the hospital in accordance with the policies established by the corporation
and provisions of the Act and other relevant legislation;
b)
be the chair of the Medical Advisory Committee;
c)
advise the Medical Advisory Committee and the Board with respect to the quality of
credentialed professional staff diagnosis, care and treatment provided to the patients
of the hospital;
d)
assign, or delegate the assignment of, a member of the credentialed professional
staff to discuss in detail with any member of the medical staff any matter which is of
concern to the chief of medical staff and to report the discussion to the chief/co-chief
of the appropriate department;
e)
assign, or delegate the assignment of, a member of the credentialed professional
staff:
i.
to supervise the practice of the respective credentialed professional staff as
appropriate, for any period of time;
Page 2 of 3
ii.
f)
to receive a written report from the chief/co-chief of the appropriate
department;
when necessary:
i.
under emergency conditions, and whenever possible in consultation with the
appropriate department chief, restrict or suspend temporarily any or all
privileges of any member of the credentialed professional staff until such time
as an emergency meeting of the Medical Advisory Committee and/or its
executive can be arranged in;
ii.
assume, or assign to any other member of the credentialed professional staff,
responsibility for the direct care and treatment of any patient in the hospital
under the authority of the Public Hospitals Act; and
iii.
notify the chief executive officer and, if possible the patient, with respect to
such aforementioned assignment.
g)
ensure there is a process for participation in continuing medical education and
medical research;
h)
support an effective process of medical staff self-government through the medical
staff association; and
i)
support the process of program management by participating in its development and
by providing advice regarding program management issues which influence patient
care.
Supervisory Role for Medical Department Chiefs and Programme Physician Directors:
a)
Ensure a process for the regular review of the performance of chiefs of departments
and program physician directors;
b)
Delegate appropriate responsibility to the chiefs of departments, and
i.
receive and review recommendations from chiefs of departments regarding
new appointments, reappointments and changes in status including changes
in privileges;
ii.
ensure chiefs of departments complete annual reviews and make
recommendations concerning appointments and reappointments and that all
recommendations are forwarded to the credentials committee.
Page 3 of 3
CATEGORY:
POLICY #:
II-11
SUBJECT:
CHIEF OF STAFF PERFORMANCE MANAGEMENT AND
EVALUATION
Appointment of the Chief of Staff is a key appointment which is the direct responsibility
of the Board. Performance evaluation of the Chief of Staff is the process of reviewing
and evaluating his/her performance based on progress towards achieving mutually
agreed objectives. A formal performance appraisal provides for regular review and
assessment and an opportunity for the Board to discuss expectations with the Chief of
Staff. It also allows the opportunity for discussion of core competencies and personal
development goals.
Guiding Principles:
i)
Performance management supports, reinforces and integrates the achievement
of strategic and business plan results with individual performance goals.
ii)
Performance objectives, measures and indicators will be established.
Performance commitments and measures will be set at a level that reflects the
high level of performance expected.
iii)
Performance management focuses both on improving organizational
performance, processes and structure and on enhancing the Chief of Staff’s
performance.
Process:
1. The Chief of Staff will develop annual performance objectives in consultation with
the MAC, the CEO and Chair, for initial discussion with the Human Resources
Committee, which will then recommend the performance objectives to the Board
for approval each March/April.
2. The Chief of Staff performance review process will be the responsibility of the
Chair and the Chair of the Human Resources Committee, in consultation with the
Chief of Staff and the CEO. The review process will commence annually in the
month of October (mid-year review) and March/April (year-end review).
3. All Directors will be requested to provide feedback annually in a standard format
on the performance of the Chief of Staff. The Chair and Chair, Human Resources
Committee will then compile the feedback and develop the performance review
documentation.
4. The Chair and Chair, Human Resources Committee will provide a report to the
Board in an in camera session, on the Chief of Staff’s performance relative to
both achievement of the goals and the assessment of core competencies.
5. The Chair will communicate the results of the evaluation to the Chief of Staff.
Page 2 of 2
CATEGORY:
POLICY #:
II-12
SUBJECT:
CHIEF OF STAFF COMPENSATION
The Board is responsible for establishing an appropriate and competitive compensation
package for the position of Chief of Staff in order to:
i)
attract and retain a highly skilled Chief of Staff with requisite competencies;
and
ii)
reward meritorious performance.
The compensation package paid to the Chief of Staff will be set out in a properly
prepared Board-approved employment contract between the Corporation and the Chief
of Staff.
In establishing the compensation package, consideration will be given to market rates
paid for similar positions within the local geographic area and within the Province,
particularly as applicable to public sector employment. The total compensation
package1, for the Chief of Staff will include the sum of base salary, vacation, incentive
compensation, benefits, and perquisites. In keeping with all applicable legislation, Chief
of Staff compensation will be linked to the achievement of agreed upon performance
objectives including targets set out in the annual quality improvement plan.
Adjustments to the compensation package will be considered on a regular basis, giving
consideration to cost of living changes, market rates, and changes in duties or
requirements. Changes to the compensation package will only be made upon Board
approval, and will generally be made at the time of the annual reviews. Determination
and payout of incentive compensation will be made once all the applicable information is
available. The Chair of the Human Resources Committee will approve the incentive
compensation calculation.
The Board, through the Human Resources Committee, will annually review the Chief of
Staff compensation for possible annual adjustments, subject to the Chief of Staff
meeting performance expectations as determined through the performance review
process, and within the limits of the overall salary budget set by the Board.
1
In keeping with all relevant legislation
CATEGORY:
POLICY #:
II-13
SUBJECT:
REPORTING ON COMPLIANCE
The Directors understand that their fiduciary duties include the duties imposed by
statute.
The CEO shall ensure that processes and operating policies are in place to ensure
compliance with legislation (federal/provincial/municipal), statutory filings and any
associated risks; and will report to the Board on the status of statutory filings,
compliance with legislation (federal/provincial/ municipal) and any associated risks.
The CEO will report to the Board on a quarterly basis on the Corporation’s compliance
with the following items:
• The Corporation has, as required by law, paid all:
i)
salary, wages and vacation pay owing to employees of the Corporation;
ii)
remittances for employee income tax deductions, Canada Pension Plan (CPP)
and Employment Insurance (EI) premiums and contributions;
iii)
remittances for required deductions for payments to non-residents;
iv)
Workplace Safety and Insurance Board (WSIB) premiums;
v)
Employer Health Tax (EHT); and
vi)
Harmonized Sales Tax (HST).
The CEO will report to the Board on an annual basis on the Corporation’s compliance
with the following items:
• The Corporation is in compliance in all material respects with occupational health and
safety legislation and all appropriate steps are being taken to maintain a safe working
environment, including the following:
i)
a safety committee is in place;
ii)
safety committee meeting minutes are being maintained;
iii)
the safety committee’s recommendations and the senior management team’s
responses are being recorded;
iv)
actions are taken, where appropriate;
v)
safety manuals are up-to-date;
vi)
hazardous materials are identified;
vii)
there is proper maintenance of signage;
viii)
ongoing training is being performed; and
ix)
a proper procedure is in place for monitoring compliance on an ongoing basis.
• Compliance with environmental legislation and regulations.
• Directors’ and officers’ liability insurance is in place and coverage is suitable and in
accordance with risk, the indemnity amount is sufficient in light of risk, all premiums
have been paid, and the policy is up-to-date.
•
In keeping with the Broader Public Sector Accountability Act, 2010, the Corporation
will prepare all required CEO attestations on the Corporation’s compliance
concerning:
i)
the completion and accuracy of reports required on the use of consultants;
ii)
compliance with the prohibition on engaging lobbyist services using public
funds;
iii)
compliance with the expense claim directives consistent with the Broader
Public Sector Directives; compliance with the perquisite directives issued by
the Broader Public Sector Directives; and
iv)
compliance with the procurement directives issued by the Broader Public
Sector Directives.
The Board will approve all such attestations. The Corporation will post all such Boardapproved attestations on its website.
Page 2 of 2
CATEGORY:
POLICY #:
II-14
SUBJECT:
WHISTLEBLOWING
1. PURPOSE AND APPLICATION
The purpose of this Policy is to encourage and enable the reporting of alleged or potential
wrongdoing and violations of Hospital policies related to ethical behaviour or business conduct,
without fear of reprisal.
Alleged or potential wrongdoing related to ethical behaviour or business conduct may include:
•
•
•
•
•
Questionable financial, accounting controls, audit practices or potential violations of law.
Quality or malpractice of care, including abuse of patients.
Environmental issues, including failure to comply with legislation or policies concerning
dangerous goods or hazardous substances.
Violations of behavior and conduct policies, conflicts of interest or other human
resources policies and legislation.
Breach of contract and negligence or failure to comply with legislation including criminal
offences.
The Policy cannot directly address every situation in which Individuals may find themselves, but
it provides a set of principles, rules and ethical standards to be used as a guide for the day-today conduct of business.
This Policy supports and follows from the reporting provisions in other policies of the Hospital:
•
•
•
•
•
Employees, Professional Staff, volunteers and students/medical learners across all sites
of the Hospital may also report violations of this Policy on a confidential basis through
the external service provider, ClearView Connects. Please see section 3.1(2).
A matter involving the Chief of Staff, the Chief Executive Officer or a Board Director must
be reported to the Board Chair.
Board Directors must follow the Process for Resolution outlined in the Board’s Conflict of
Interest Policy in the event of an actual or perceived conflict of interest.
The Code of Conduct Policy for all employees, Professional Staff, volunteers,
students/medical learners, and the Professional Staff Code of Conduct Policy and
Procedure require all Individuals to report violations of the codes of conduct to their
manager/leader.
The Workplace Discrimination, Harassment and Violence Prevention Policy and
Procedure permits complaints of misconduct as well as the reporting of workplace
violence events to Human Resources either directly or through a manager.
Page 1 of 13
This Policy is in effect during working hours and at work-related functions, on or off the
Hospital’s premises.
1.1 Application
All Board directors, employees, persons with practicing privileges (physicians, dentists,
midwives and RNs in the extended class), volunteers, students/learners, independent and
external contract workers, and all individuals who represent the Hospital are bound by this
Policy. For the purposes of this Policy, everyone included in the scope of this Policy will be
referred to as “Individuals”.
2. POLICY AND GUIDING PRINCIPLES
Implementation of this Policy will be guided by the following principles and policy statements.
• The Hospital complies with all relevant laws and regulations.
• All policies support and embody the Hospital’s core values.
• The Hospital maintains high standards of business and ethical conduct and applies these
standards to all matters of business.
• All complaints will be dealt with promptly, be fully reviewed and/or investigated as
appropriate, in a fair and equitable manner, ensuring a respectful process is followed for
those involved.
• There will be no reprisals against anyone reporting in good faith under this Policy.
• Confidentiality will be protected to the maximum extent possible.
2.1 Reporting Responsibility
Any Individual who is aware of or suspects a breach/violation of Hospital policies related to
ethical behaviour or business conduct, including a violation of the behavior and standards of
conduct or potential violations of law, or has concerns relating to business, financial, accounting
or auditing practices, is responsible for reporting the concern as soon as possible.
2.2 No Reprisals
Individuals reporting in good faith under this Policy will not suffer harassment, retaliation or
adverse employment consequences (for example, demotion, denial of promotion or
compensation) even if after the investigation has been completed, the allegations are not
substantiated.
Page 2 of 13
Individuals who experience any form of retaliation before or after submitting a report should
immediately inform their manager, a senior member of the Human Resources group or the
General Counsel.
An Individual who retaliates against another Individual for reporting in good faith will be subject
to discipline, which may include termination or removal.
Failure to report a violation may lead to disciplinary action.
2.3 Acting in Good Faith
In making a report, an Individual must be acting in good faith with reasonable grounds for
believing there is alleged or potential wrongdoing, a breach of the standards of behavior or
questionable financial or business practices. An Individual who makes an unsubstantiated
report, which is knowingly false or made with malicious intent, will be subject to discipline, up to
and including termination or removal.
2.4 Confidentiality
Anyone involved in a complaint process will keep reports confidential to the maximum extent
possible, consistent with the Hospital’s legal and ethical responsibilities, including the need to
conduct an effective investigation. Please note that confidentiality may not mean anonymity.
The Hospital will accept reports under this Policy on an anonymous basis.
The Hospital will not tolerate any attempt by another Individual or group to identify an Individual
who reports in good faith on a confidential or anonymous basis.
3. PROCEDURE FOR REPORTING COMPLAINTS
The Hospital recognizes the importance of providing Individuals with multiple channels through
which to report issues of alleged or potential wrongdoing. The more channels offered to
Individuals, the more comfortable they will feel in the reporting process.
Individuals may file a complaint with their immediate manager/leader, or with the General
Counsel, please refer to the Internal Reporting Processes (Appendix C). If they are not
comfortable reporting through Internal Reporting Processes, they have the option of filing an
anonymous complaint through the Hospital’s independent, external service provider, ClearView
Connects. Please see section 3.1(2).
3.1 How to File a Complaint
1. Any Individual who is aware of, or suspects a breach of the standards of behaviour or of
alleged or potential wrongdoing under this Policy, will report the concern directly to the
General Counsel. Alternatively, the Individual may report the concern to his/her
Page 3 of 13
manager/leader who will forward the complaint to the General Counsel for review and/or
investigation, please refer to the Internal Reporting Processes (Appendix C).
2. If the Individual wishes to remain anonymous, s/he may contact the Hospital’s
independent, third party service provider (at this time, ClearView Connects).
Hotline at 1.866.921.0105, or
www.clearviewconnects.com; or
P.O. Box 11017, Toronto, ON., M1E 1N0.
The external service provider creates an anonymous report that is referred to the
General Counsel and Chief Executive Officer (see Appendix B - ClearView Connects for
details). The process is completely confidential.
3. The General Counsel and CEO are accountable for ensuring the matter is investigated
and appropriate action is taken. If the matter concerns a member of the professional or
credentialed staff, the Chief of Staff will also be involved.
4. The person will be advised of the complaint against them and be given an opportunity to
respond.
5. The actions that may be taken to address a violation will depend on the particular
circumstances, and consequences may include, but are not limited to, discipline up to
and including termination or the withdrawal of privileges.
If an Individual has a complaint pertaining to the Chief Executive Officer, Chief of Staff, or a
Board Director, the complaint will be sent to the Board Chair. The complaint will be investigated
through the Priorities and Planning Committee (PPC) of the Board. External investigations are
required for complaints involving the CEO and/or the Chief of Staff to avoid potential conflicts.
If an Individual has a complaint pertaining to the Board Chair, it will be sent to the PPC Chair for
review and investigation.
4. INVESTIGATION OF COMPLAINTS
4.1 Principles for Investigating Complaints
The Hospital will conduct investigations based on the following principles:
•
The investigation will be carried out fairly and without bias.
•
Those involved in the investigation will be independent of both the person who made
the report and any persons under investigation. This means they should not either be
reporting to, or supervising, any such persons.
Page 4 of 13
•
Disclosure of information will be limited to those who need to be involved in order to
carry out the investigation.
•
The person who is the subject of the report is entitled to know the substance of the
allegation(s) and have an opportunity to respond.
•
Investigations will be conducted in a timely manner.
•
The Hospital expects Individuals to cooperate during any investigation.
4.2 Responsibility for Investigating Complaints
The General Counsel and CEO are accountable for ensuring that complaints are appropriately
investigated, resolved and reported under this Policy. Managers/leaders must forward any
Whistleblowing complaints they receive to the General Counsel. Complaints relating to the
CEO, Chief of Staff or a Board Director will be forwarded to the Board Chair.
For Individuals below the CEO and Chief of Staff levels, the General Counsel and CEO will
evaluate the nature of the complaint and determine the appropriate level of response. If the
complaint relates to a Professional Staff member, the CEO, General Counsel and Chief of Staff
will evaluate the nature of the complaint and determine the appropriate level of response.
The General Counsel and CEO may delegate responsibility for overseeing or investigating
specific matters to external counsel or other staff, including the VP, Human Resources,
Volunteer Resources and Organizational Effectiveness or the Chief of Staff. Complaints may be
referred to the appropriate law enforcement or regulatory authorities as appropriate.
If the Board Chair receives a complaint about a Board Director, or the PPC Chair receives a
complaint regarding the Board Chair, the investigation will be coordinated with the CEO.
If the CEO has an actual or perceived conflict, the complaint must be sent to the Board Chair
and the investigation will be coordinated with the General Counsel.
If the General Counsel has an actual or perceived conflict, the complaint must be sent to the
CEO. The CEO will evaluate the nature of the complaint and determine the appropriate level of
response.
4.3 Whistleblowing Files
Complaint and investigation files must be kept separate from employee/physician/learner files
and stored in a secure location with access limited to those responsible for conducting the
investigation. No record of a complaint will be kept in any employee/physician/learner file
unless improper conduct is found that results in disciplinary action. In that case, the outcome of
the investigation will be reflected in the file of the disciplined employee/physician/learner. Please
refer to the Professional Staff Code of Conduct for details related to professional staff files.
Page 5 of 13
5. SUPPORT FOR INDIVIDUALS
Anyone involved in an investigation, whether as a complainant, alleged offender or person
interviewed, may wish to use the confidential counseling service that is available to all
Individuals through the Hospital’s Employee Assistance Program.
Guidanceresources
Toll Free Number: 1.855.410.7628
TDD: 1.877.373.4763
https://guidanceresources.com/groWeb/login/login.xhtml
Your company Web ID: EAP4THP
6. REPORTING TO THE BOARD
6.1 Annual Reports to the Board
The Board will receive annual reports from the PPC Chair and the CEO on Whistleblowing. The
report will provide an overview of the number of complaints received, the nature of the
complaints, the number of complaints substantiated or resolved and a general description of
how they were resolved. It will also identify any trends or risk issues to be addressed by the
Hospital and/or Board. These reports will not contain information that could identify the
individuals involved.
6.2 Specific Whistleblowing Complaints
The CEO will report to the Board, through the PPC, specific Whistleblowing incidents as
required.
The following criteria are designed to provide guidance to the CEO as to whether the PPC
should be advised of a specific Whistleblowing incident:
• Poses a reputational risk to the organization.
• It is likely to be made public.
• Outside authorities need to be advised.
• Law suit is likely.
• Significant breach of organizational values.
• At the CEO’s discretion based on the severity or nature of the complaint.
The Board Chair will receive specific whistleblowing complaints regarding the Chief of Staff
and/or the CEO directly.
7. EDUCATION/COMMUNICATIONS
There will be a full communications plan for Individuals on the new integrated Whistleblowing
Policy. The communications will include a message from the CEO, Frequently Asked Questions,
and an overview of the complaints process. The Policy will be posted on the Hospital’s intranet
Page 6 of 13
site(s). On an annual basis, the Hospital will communicate reminders to Individuals about the
process for reporting complaints, including anonymous complaints.
8. RELATED POLICIES
2008/06/17
2010/06/29
2010/08/06
2012/07/03
2006/03/17
2006/03/17
2012/03/30
CVH Code of Conduct - POL
CVH Code of Conduct - PRO
THC Code of Conduct - PRO
Professional Staff Code of Conduct – POL INT
CVH Workplace Harassment - POL
CVH Workplace Harassment - PRO
CVH THC Conflict of Interest – POL INT
9. APPROVED BY
2012/08/29
2012/10/11
2012/11/06
2012/11/16
Senior Management Team
Risk Management Committee (tbc)
Governance Committee (tbc)
Board of Directors (tbc)
10. SUPERCEDES
2008/02/29
2008/02/29
2010/07/29
CVH Whistleblowing - POL
CVH Whistleblowing - PRO
THC Whistleblower Policy - POL
Page 7 of 13
APPENDIX A - FILING OF COMPLAINTS SUMMARY CHART
If the Complaint is About….
File Complaint With…
Investigates Complaint
Board Chair
Chair, Priorities and Planning
Committee
Committee appoints an
external investigator.
Board Director
Board Chair
Chief Executive Officer or
Chief of Staff
Board Chair
Physicians and Credentialed
Staff
Chief of Staff or to the
General Counsel
Determined on a case-bycase basis by Chief of Staff,
General Counsel and CEO.
May delegate responsibility to
others in organization or to an
Medical Learners
Direct Supervisor, the
Medical Education Office or to
the General Counsel
Determined on a case-bycase basis by Chief of Staff,
General Counsel and CEO,
and as per the University’s
policies and processes.
All Other Individuals in Scope
of this Policy
Direct Supervisor or Manager;
or directly to the General
Counsel
Determined on a case-bycase basis by General
Counsel and CEO. May
delegate responsibility to
others in organization or to an
General Counsel
CEO
CEO may delegate
responsibility to others in
organization or to an external
investigator.
Page 8 of 13
APPENDIX B - CLEARVIEW CONNECTS
The following outlines the three reporting processes available to Individuals through ClearView
Connects – an independent, external service provider. Individuals may make anonymous
complaints through ClearView Connects, or may identify themselves.
1. Web Site Reports
When an Individual chooses to make a report through the ClearView Connects website, they log
on to www.clearviewconnects.com from any internet-accessible computer, anywhere in the
world. They enter the organization’s name “Trillium Health Partners” and begin the reporting
process. Once they enter the Hospital name, they are immediately taken into a fully encrypted
portion of the ClearView Connects web application.
Throughout the web site reporting process, no personal information is specifically requested that
could identify the reporter. Furthermore, instructions are provided warning the reporter not to
divulge any personal information that would identify them if, in fact, they prefer not to be
identified. As well, when reports are submitted using the web-based reporting process, the IP
address is not recorded in the ClearView Connects system. This ensures anonymity for the
reporter, and confidentiality of the information provided within the security of the ClearView
Connects system.
At the conclusion of the reporting session, the ClearView Connects system generates a unique
login and password for the reporter. The system encourages the Individual to write this
information down and keep it in a safe place, as ClearView Connects DOES NOT keep track of
these login and password pairings. This is critical to protect the security of the information in the
system, as well as to protect and maintain the anonymity of the Individual submitting the report.
Once the report has been submitted, the system immediately generates automatic email
notifications and sends these to the General Counsel and CEO at the Hospital who have access
to review reports.
2. Telephone Reports
It is important to note that the process an Individual follows when submitting a report using the
telephone hotline with live operator is exactly the same as if they were submitting the report
using the web-based tool. When an Individual chooses to make a report using the ClearView
Connects telephone hotline system, they call a special toll free number (1.866.347.7417). The
Individual is given the option of speaking with a live ClearView Connects agent, or leaving a
voice mail message with their report information.
Page 9 of 13
Live Agent
The Individual advises the ClearView Connects agent that they wish to make a verbal report.
ClearView Connects does not request personal information over the telephone from the
Individual calling. Furthermore, instructions are provided warning the Individual not to divulge
any personal information that would identify them, if in fact; they prefer not to be identified. It is
ClearView Connects’ policy not to subscribe to caller ID services.
The ClearView Connects agent enters the report from the Individual verbatim, directly into the
ClearView Connects online reporting system. No separate handwritten notes are taken by the
agent that could be read later by another person (the ClearView Connects call centre is a
paperless environment). As information is being entered into the system, it is fully encrypted.
At the conclusion of the reporting session, the system generates a unique login and password
for the reporter. The system encourages the Individual to write this information down and keep
it in a safe place, as ClearView Connects DOES NOT keep track of these login and password
pairings. This is critical to protect the security of the information in the system, as well as to
protect and maintain the anonymity of the Individual submitting the report.
Once the report has been submitted, the system immediately generates automatic email
notifications and sends these to the General Counsel and CEO at the Hospital who have access
to review reports.
Voice Mail
The Individual’s voice mail is transcribed verbatim by a ClearView Connects agent and is
entered directly into the web-based reporting system. Unless specifically instructed by the
Individual who leaves the voicemail message, no personally-identifiable information is included
in the transcribed voicemail report. Please note that when an Individual submits a report using
the voicemail option, there is no further follow up available with the Individual, since the
voicemail system does not generate and assign a unique login and password for them. The
system immediately generates automatic email notifications and sends these to the General
Counsel and CEO at the Hospital who have access to review reports.
3. Mail Reports
When an Individual chooses to make a report by mail, they prepare their information in any
format they wish. They should be careful to leave out any personal details if they do not wish to
be identified. They may include any documents they feel substantiate the allegations contained
in their report. They will mail the report to a confidential Post Office Box [P.O. Box 11017,
Toronto, ON., M1E 1N0]. When ClearView Connects receives the report by mail, it will be input
into the ClearView Connects system verbatim, along with any documents that have been
attached (these will be scanned electronically and attached to the electronic report). The
Page 10 of 13
Individual’s name will not be included anywhere in the report unless the Individual has
specifically given authorization for their name to be used. Note that when an Individual submits
an anonymous report using the regular mail option, there is no further follow up available with
the employee, since there is no way to communicate a unique log in and password. The system
immediately generates automatic email notifications and sends these to the General Counsel
and CEO at the Hospital who have access to review reports.
Interactive Dialogue Capability
When a report is received by the ClearView Connects system, automatic email notifications are
immediately sent to the General Counsel and CEO who have access to review the reports.
They log onto the system using a secure login and password provided by ClearView Connects
(note – passwords are changed quarterly by ClearView). After reviewing the report, there is an
opportunity for them to ask the Individual additional questions through the web system to
validate information in the report or to gather additional information to assist in an investigation.
When the Individual logs back into the system – or calls the toll free hotline – to check the status
of their report, they will see that additional information has been requested by the General
Counsel and will have an opportunity to answer the question(s) if they choose.
Page 11 of 13
APPENDIX C – INTERNAL REPORTING PROCESSES
A. Collection of Information
The following outlines the internal reporting details required to initiate an investigation:
i)
ii)
iii)
iv)
To the extent possible, be specific about names, departments, individuals, documents,
policies, etc. In addition, try to remember locations, dates, times, and who was involved.
Please see Section 4.2 of the Policy for complaints involving the General Counsel, the
Chief of Staff, the CEO, a Board member or the Board Chair.
Collect and attach a copy of any documents to support the concern being raised (to the
extent the Individual opted to provide his/her identity).
Include details of any previous instances in which this concern was reported, to whom it
was reported, when and with what outcome.
Upon collection of the above information by the appropriate leader under the category “File a
Complaint With” in Appendix A (“Hospital Agent”), the Individual’s report shall be escalated in
accordance with Sections 3, 4 and 6 of the Policy.
B. Mechanisms of Internal Report
The following outlines the three reporting mechanisms available to Individuals through internal
reporting. When reporting a complaint through a manager/leader, General Counsel or CEO, an
Individual has the option to remain anonymous to other bodies; or have their identity revealed in
the investigation process.
1.
In-Person
When an Individual chooses to make an in-person report, the Individual may contact the
appropriate Hospital Agent. The Hospital Agent will request from the Individual the information
outlined in Section A above.
2.
Telephone Reports
When an Individual chooses to make a report using the telephone system, the Individual is
given the option of speaking directly with the Hospital Agent, or leaving the Hospital Agent a
voice mail message with their report information.
Live Agent
The Individual advises the Hospital Agent that they wish to make a verbal report. The Hospital
Agent will request from the Individual the information outlined in Section A above. The Hospital
Agent does not request personal information over the telephone from the Individual calling.
Page 12 of 13
Furthermore, instructions are provided warning the Individual not to divulge any personal
information that would identify them if, in fact, they prefer not to be identified. Please note the
Hospital’s telephone system subscribes to caller ID services, if it is the Individual’s preference to
be anonymous, the Individual should be mindful in utilizing a telephone system with blocked
caller ID services.
Voice Mail
The Individual may leave a voicemail for the Hospital Agent describing the nature of the
reported concern; including the details outlined in Section A above.
The Individual’s voice mail is transcribed verbatim by the Hospital Agent. Unless specifically
instructed by the Individual who leaves the voicemail message, no personally-identifiable
information is included in the transcribed voicemail report.
3.
Mail Reports
When an Individual chooses to make a report by mail, they prepare their information in any
format they wish (please refer to Section A above for the information that would assist the
Hospital Agent in conducting the investigation). They should be careful to leave out any
personal details if they do not wish to be identified. They may include any documents they feel
substantiate the allegations contained in their report. The Individual will mail the report marked
“Private and Confidential” to the Hospital Agent identified in Appendix A. The Individual’s name
will not be included anywhere in the report unless the Individual has specifically given
authorization for their name to be used.
Page 13 of 13
Part III:
Program Quality
and Effectiveness
CATEGORY:
PROGRAM QUALITY AND EFFECTIVENESS
POLICY #:
III-1
SUBJECT:
QUALITY IMPROVEMENT AND SAFETY
Based on the Excellent Care For All Act, 2010, the Board:
 recognizes that a high quality health care system is one that is accessible,
appropriate, effective, efficient, equitable, integrated, patient centred, population
health focussed, and safe;
 is committed to ensuring that the Corporation is responsive and accountable to the
public, and focused on creating a positive patient experience and exceptional
outcomes, and
 believes that quality is the goal of everyone involved in delivering health care in
Ontario, and that ultimately, this health care organization should hold its executive
team accountable for its achievement.
The Corporation is committed to meeting or exceeding established and evolving
standards of quality and patient safety. The Corporation is committed to addressing
quality issues and identifying and acting upon opportunities to continuously improve
patient care and service delivery. The Board recognizes the importance of monitoring,
evaluating and continuously improving the quality of patient care and services.
The Board recognizes the importance of the safe delivery of its services, as well as the
importance of reducing or preventing the potential for injury or loss to its patients,
visitors, employees, professional staff members, students and volunteers. Embedding a
culture of patient safety throughout the corporation is an underlying principle in the
success of quality improvement. Patient safety has been defined as a patient’s “freedom
from accidental injury” when interacting in a healthcare system. Care and management
standards are integral to the achievement of this goal. Standards and quality planning
will align with the Corporation’s mission, vision, core values and corporate priorities, and
will support the goals and objectives of the Corporation’s strategic plan.
The Board is ultimately responsible for oversight and decision making related to quality
and safety issues including:
i)
reviewing and recommending policies and standards;
ii)
overseeing compliance with quality and safety related issues, including
accreditation; and
iii)
reviewing and making recommendations following adverse events.
In keeping with the requirements under the Excellent Care for All Act, 2010, the
Corporation will:

carry out patient satisfaction surveys and employee satisfaction surveys;

develop a patient declaration of values, and publicly post it;
 establish a patient relations process that reflects the content of its patient
declaration of values, and publicly post it;
 develop an annual quality improvement plan publicly post it, and provide a copy
of it to the Ontario Health Quality Council; and
 annually establish performance targets and performance metrics related to
quality and patient and staff safety for monitoring by the Quality and Program
Effectiveness Committee.
At least quarterly, the Quality and Program Effectiveness Committee will monitor the
Corporation’s quality of patient care, and patient and staff safety against the defined
performance targets and performance metrics and report to the Board.
The Board will discuss issues related to quality of patient care and patient and staff
safety on the agenda at every regularly scheduled Board meeting.
Page 2 of 2
CATEGORY:
POLICY #:
III-2
SUBJECT:
RISK MANAGEMENT
The Board must be knowledgeable about risks inherent in Hospital operations and
ensure that appropriate risk analysis is performed as part of its decision-making. In
particular, the Board:
i)
oversees the CEO’s risk management program;
ii)
ensures that appropriate programs and processes are in place to protect
against risk;
iii)
expects the CEO to identify unusual risks to the Corporation and ensure that
there are plans in place to prevent and manage such risks;
iv)
expects the CEO to identify and assess the associated organizational risks
when reviewing and approving resource allocation decisions;
v)
anticipates financial needs and potential risks, and develops contingency
plans; and
vi)
works with the CEO to reduce organizational risks and promote ongoing
quality improvement.
The Board is responsible for ensuring that appropriate risk management practices are in
place, and for reviewing and approving the Corporation’s variance and risk tolerance
levels.
Each Board Standing Committee will review the risks related to its mandate. The
Priorities and Planning Committee will review the enterprise risk management program
at least on an annual basis and report thereon to the Board.
The CEO is accountable for: identifying the principal organizational risks of the
Corporation; determining the Corporation's exposure to risk; and developing and
implementing a risk management framework.
The Board will annually monitor and assess the Corporation’s quantification of risks,
including asset protection, and how those risks are addressed.
CATEGORY:
POLICY #:
III-3
SUBJECT:
ETHICS FRAMEWORK
The Board has adopted will use the IDEA: Ethical Decision Making Framework and will
support its use to inform decision-making within the Corporation from the point of care to
the boardroom.
The framework (see Figure 1) incorporates the following four process steps and five
principles underlying the overall framework.
The four process steps are:
I–
Identify the facts.
Ask: What is the ethical issue?
D – Determine the relevant ethical principles.
Ask: Have perspectives of relevant individuals been sought?
E – Explore the options.
Ask: What is the most ethically justifiable option?
A – Act.
Ask: Are we (am I) comfortable with this decision?
The five principles are:
Empowerment: Strategies are in place to ensure stakeholder input from those with less
power and influence.
Publicity: The process, decisions, and rationales are transparent and accessible to
stakeholders.
Relevance: Stakeholders agree on relevant ethical values, principles, and criteria to
guide decision-making.
Revisions and Appeals: A mechanism is in place to revisit and revise decisions in light
of new facts and/or to address concerns about omissions or errors in the process.
Compliance (Enforcement): There is voluntary or public regulation of the process to
ensure that the other four conditions are met.
Figure 1
IDEA1: Ethical Decision-Making Framework
COMPLIANCE
4. Act.
1. Identify the Facts.
• Recommend
• Implement
• Evaluate
Ask: Are we (am I) comfortable
with this decision?
What is an ethical issue?
• Am I trying to determine the right
course of action?
•
•
•
•
Clinical/Medical Indications
Individual Preferences
Evidence
Contextual Features
Ask: What is the ethical issue?
• Am I asking a “should” question?
• Are values and beliefs involved?
• Am I feeling uncomfortable?
REVISIONS
& APPEALS
EMPOWERMENT
If you answered yes to any of
these questions, you may be
encountering an ethical issue.
PUBLICITY
3. Explore the Options.
2. Determine the Relevant
Ethical Principles.
1
•
•
•
•
Harms & Benefits
Strengths & Limitations
Laws & Policies
Mission, Vision, Values
Ask: What is the most ethically
justifiable option?
1
• Nature & Scope
• Relative Weights
RELEVANCE
Ask: Have perspectives of relevant
individuals been sought?
The IDEA: Ethical Decision-Making Framework builds upon the Toronto Central Community Care Access Centre Community Ethics
Toolkit (2008), which was based on the work of Jonsen, Seigler, & Winslade (2002); the work of the Core Curriculum Working Group at
the ‘University of Toronto Joint Centre for Bioethics; and incorporates aspects of the accountability for reasonableness framework
developed by Daniels and Sabin (2002) and adapted by Gibson, Martin, & Singer (2005).
Page 2 of 2
CATEGORY:
POLICY #:
III-4
SUBJECT:
RESPECT FOR DIVERSITY
The Corporation, as represented by the Directors, officers, Professional Staff members,
Board committee members, employees, volunteers and students, values and respects
the diversity of its patients and their families, the community and each other.
The Corporation is committed to being an organization which recognizes the dignity and
worth of every person.
In addition to complying with applicable laws, the Corporation will:
• establish the principles, processes and responsibilities essential for creating and
maintaining a positive work environment consistent with applicable laws;
• promote a climate of understanding and mutual respect for the dignity and worth of
every person;
• be courteous and tactful in all interactions;
• respect the customs and beliefs of individuals consistent with the mission of the
Corporation;
• strive towards equity and fairness and work with honesty, integrity, respect and good
faith;
• be sensitive to potential barriers to accessibility;
• provide for equal rights and opportunities without discrimination; and
• promote respectful relationships with health care partners and community
stakeholders
CATEGORY:
POLICY #:
III-5
SUBJECT:
PRIVACY, SECURITY AND CONFIDENTIALITY OF
INFORMATION
In accordance with the Corporate By-law (Article 13), every Director, officer, Professional
Staff member, committee member, employee, volunteers and students and agent of the
Corporation shall respect the confidentiality of matters:
i)
brought before the Board;
ii)
brought before any committee;
iii)
dealt with in the course of the employee's employment or agent's activities; or
iv)
dealt with in the course of the Professional Staff member's, volunteer’s or
student’s activities in connection with the Corporation.
In compliance with the Public Hospitals Act, the Board recognizes the importance of
respecting and ensuring the confidentiality of all patient and employee-related
information.
Every Director, officer, Professional Staff member, Board committee member, employee,
volunteer and student of the Corporation will respect the confidentiality of matters
brought before the Board or before any Board committee, or dealt with in the course of
the individual’s employment or other activities in connection with the Corporation.
All Directors must adhere to the by-laws and policies and procedures on privacy,
security and confidentiality of information including, without limitation, confidential
information, release of patient information, facsimile of patient information, release of
information to the media and personnel records.
The CEO is responsible for ensuring the protection of the personal information of
patients and their families, Professional Staff members, employees, volunteers and
students, and all corporate and business information.
The CEO will take reasonable steps to ensure that such organizational policies are
implemented consistent with legal requirements and enable the Corporation to handle
such information in a secure and confidential manner.
CATEGORY:
POLICY #:
III-6
SUBJECT:
ACCESS TO INFORMATION
Consistent with the Board’s commitment to good governance practices, timely access to
information, appropriate protection of personal privacy, and appropriate protection of other
information that is exempted or excluded from disclosure under the Freedom of Information and
Protection of Privacy Act, the Board will make available to the public:
•
the statement of Board and Director roles, responsibilities and accountabilities;
•
a list of elected and ex-officio Directors and their attendance records;
•
policies governing the Board and Board standing committees;
•
a report on the Corporation’s performance as part of its Annual Report;
•
the Corporation’s Quality Improvement Plan, in compliance with the Excellent Care for
All Act, 2010;
•
information about expense claims in compliance with any directives made under the
Broader Public Sector Accountability Act, 2010; and
•
upon request, information that is subject to disclosure under the Freedom of Information
and Protection of Privacy Act.
•
minutes of Board of Director meetings
CATEGORY:
POLICY #:
III-7
SUBJECT:
COMPLAINTS (PATIENT CARE AND OTHER)
It is important to patients, their families, and the community at large that all complaints
are dealt with in a timely, impartial and confidential manner. Consistent with the
Excellent Care for All Act (ECFAA), it is the policy of the Board to support and monitor
the Corporation’s patient relations process to ensure facilitation, mediation and
resolution of complaints.
The Board is accountable for ensuring that there is a complaints management process in
place. Trends are reported to the Board through the Quality and Program Effectiveness
Committee.
If a written or verbal complaint is received by a member of the Board, the member of the
Board shall forward the complaint to the appropriate Patient Relations Officer.
CATEGORY:
POLICY #:
III-8
SUBJECT:
RESEARCH
The Corporation is committed to:
 seeking solutions to health issues by fostering learning, discovery, and innovation;
 advancing scientific knowledge and its dissemination into practice;
 achieving excellence in basic and applied sciences research;
 maintaining and developing research partnerships and collaborations; and
 providing a supportive environment, infrastructure, resources, and facilities to achieve each
of the above.
The Corporation may permit its facilities and resources to be used for research-related activities
in health and related fields. The Corporation, within the limits of its available resources, and
having due regard for the intended purpose of patient care funding, may support research
initiatives that meet the following criteria:
i)
The research is consistent with the Corporation’s vision, mission, core values, strategic
plan and operating plan.
ii)
The research conforms to corporate policies and guidelines on research, research ethics
and research standards, professional conduct, and the protection of human research
subjects.
iii)
The deliverables of the research and the ownership of any new apparatus or procedures
will be subject to the Corporation’s intellectual property policy and/or the research
agreements with research partners, collaborators and supporters.
Each proposed research study (human and non-human) shall be evaluated against current
standards to ensure sound ethical and scientific merit and conduct. This will be enabled
through standard review processes of the Corporation. The broad principles, rights and
obligations that will govern the conduct of research, and the oversight, management and
funding of research, will be determined through affiliation agreements, and research
agreements with other academic and research partners, collaborators and supporters.
All research studies that involve human subjects shall undergo review by the Research Ethics
Board (REB) to ensure compliance with Good Clinical Practice Guidelines, the Tri-Council
Policy Statement 2 (TCPS 2), and best practices to protect personal health information and the
safety and welfare of human research subjects. This also applies to research involving human
remains, cadavers, tissues, biological fluids, embryos and fetuses. Employees, privileged staff,
professional staff, agents, contractors, students, and volunteers of the Corporation that are
conducting human subjects research within or under the auspices of the Corporation, are
required to adhere to the TCPS.
Under the Research Policy, the Board of Directors is accountable for the following:

To establish the Research Ethics Board (REB) within the Corporation;

To require the REB to maintain an active Institutional Review Board (IRB) and Institutional
Review Board Organization (IORG) registration with the office of Human Research
Protections (OHRP);

To require the Corporation to maintain and retain an active FederalWide Assurance (FWA)
with the OHRP;

To require the REB to operate as an independent objective review board;

To require the REB to make independent determinations regarding whether to approve or
disapprove human subject research protocols based on whether or not human subjects are
adequately protected;

To require the REB to have protocols in place, warranting an unbiased REB review,
objective and free from conflict of interest to prevent compromising the objectivity of the
review process;

To require the Corporation to have a formal appeal mechanism in place to enable
researchers to appeal a negative REB determination; and

To develop the Intellectual property policy for the Corporation and review it on a regular
basis.
The mandate of the REB is to approve, reject, propose modifications to, or terminate any
proposed or ongoing research involving human subjects that is conducted under the auspices of
the Corporation. Specifically, the REB will review all human subjects research conducted that
meets any of the following criteria. The research:

is conducted by any of the Corporation’s employees, privileged staff, professional staff,
agents, contractors, students, and volunteers in relation to their role within the Corporation;
or

is conducted at any of the Corporation’s sites; or

is conducted with any hospital resources; or

is being performed as part of the Corporation’s training program; or
Page 2 of 3

the name of the Corporation will be used as part of an individual’s credentials for any type of
publication, presentation or abstract.
The Corporation retains the authority to reject any REB approved research. A decision made by
the REB to reject research may not be overridden by the Corporation.
The Corporation will have in place a policy for granting the use of an external REB for the
ethical review of human subject research conducted within or under the auspices of the
Corporation, and similarly for permitting the use of the Corporation’s REB for the ethical review
of human subjects research conducted within or under the auspices of an external organization.
This policy will establish a standard process to determine when an external REB will be used in
place of the Corporation’s REB, and when the Corporation’s REB will be used by external
organizations. All authorization for delegation of REB review and oversight must be granted by
the Board or Board’s delegate.
Page 3 of 3
CATEGORY:
POLICY #:
III-9
SUBJECT:
RESEARCH ETHICS BOARD APPEALS
Purpose: This policy sets out the components of and requirements and procedure for appealing
a Research Ethics Board (REB) decision.
Application: All employees, privileged staff, volunteers, students/learners, independent and
external contract workers, and all individuals who engage in research conducted within or under
the auspices of the organization are bound by this Policy. For the purposes of this Policy,
everyone included in the scope of this Policy will be referred to as ‘Individuals’.
2. BACKGROUND
As required by the Tri-Council Policy Statement 2 (TCPS2) and Board Policy III-8 Research,
where a researcher:
1. does not receive ethics approval by the REB, or
2. receives approval conditional on revisions that they find compromise the feasibility or
integrity of the proposed research,
the researcher will be entitled to reconsideration by the REB. If the REB reconsideration efforts
are not successful and the REB has refused ethics approval of the research, the researcher
may appeal the REB decision through an established appeal mechanism.
The appeal process is not a substitute for the REB and researcher working closely together to
ensure high-quality ethical research, nor is it a forum to merely seek a second opinion.
The researcher and REB should make every effort to resolve disagreements they may have
through deliberation, consultation and advice.
This policy sets out the components and requirements of the REB appeal mechanism at Trillium
Health Partners.
3. POLICY
3.1. Reconsideration by the REB
3.1.1.Before a request for appeal can be considered by the REB Appeal Board, the
researcher must first attempt to resolve the matter through a formal reconsideration
request to the REB.
3.1.2.Researchers have the right to request, and the REB has an obligation to provide,
prompt reconsideration of decisions affecting a research project.
3.1.3.In order to facilitate reconsideration by the REB the researcher must:
(i)
(ii)
justify the grounds on which they request reconsideration by the REB, and
indicate any alleged breaches to the established research ethics review
process, or any elements of the REB decision that are not supported by the
TCPS2.
3.1.4.The REB shall review a reconsideration request at their next convened full board
meeting, and shall communicate their decision in writing within 2 weeks of reaching
that decision.
3.1.5.If a disagreement between the researcher and the REB cannot be resolved through
the reconsideration process, the researcher shall have the option of appealing the
REB decision(s) through the established appeal mechanism.
3.2. Appeal of REB Decision
3.2.1.All requests for appeal of the REB’s decision must meet the following Eligibility
Criteria for Appeal:
(i)
The researcher and the REB must have fully exhausted the reconsideration
process as described above and the researcher should document the
demonstrated effort to resolve the matter through the REB’s existing
reconsideration processes (consultations, ad hoc meetings, ongoing
correspondence and communication).
(ii)
The REB must have issued a final decision before the researcher initiates an
appeal.
(iii)
The researcher must justify the grounds on which they are requesting an
appeal.
(iv)
The researcher must indicate any breaches of the research ethics review
process or any elements of the REB decision that are not supported by the
TCPS2 (i.e. jurisdictional and or procedural breaches).
(v)
The researcher must submit written documentation that confirms criteria (i)
through (iv) have been met to the Research Office within 60 days of
completion of the reconsideration process with the REB.
3.2.2.The Appeal Board
The Appeal Board shall function impartially, provide a fair hearing to those involved, and
provide reasoned and appropriately documented opinions and decisions. Both the
researcher and a representative of the REB shall be granted the opportunity to address
the Appeal Board, but neither shall be present when the Appeal Board deliberates and
makes a decision. Appeal Board decisions on behalf of the organization shall be final,
Page 2 of 5
and will be communicated in writing (in print or by electronic means) to researchers and
to the REB whose decision was appealed.
3.2.3.Appeal Board Constitution
Appeal Board membership shall reflect the range of expertise, membership and
knowledge similar to that of the organization’s REB and will be formed on an ad hoc
basis. The organization will establish and maintain a listing of potential candidates for
consideration in establishing the Ad Hoc Appeal Board. Potential candidates will be
assessed by the Research Office in relation to their ability to partake in the appeal
process for the appeal submitted, and selected based on this assessment. The
assessment and selection process will take into consideration individuals:
• potential, perceived or actual conflict of interest in the matter, and
• expertise that can be applied in review of the necessary documentation.
Following the membership assessment process the Research Office will provide the
Board of Directors with a listing of potential candidates that:
• are free from potential, perceived or actual conflict of interest in the matter, and
• collectively reflect the minimum REB membership criteria.
The Board of Directors will establish the Ad Hoc Appeal Board from the listing of eligible
potential candidates provided by the Research Office.
3.2.4.Appeal Board Authority
The Appeal Board shall function impartially, provide a fair hearing to those involved, and
provide reasoned and appropriately documented opinions and decisions.
The Appeal Board will review the material submitted by the researcher and REB in
relation to the matter being appealed. The Appeal Board will decide, in its sole and
absolute discretion, whether the matter is eligible to be reviewed and resolved through
the appeals mechanism.
If the request for appeal is deemed eligible by the Appeal Board, the Appeal Board will
convene to discuss, deliberate and vote on the matter.
The Appeal Board shall have the authority to review negative decisions made by the
REB. In so doing, it may approve, reject or request modifications to the research
proposal. Its decision on behalf of the organization shall be final.
If the request for appeal is denied by the Appeal Board, the Appeal Board must
communicate their findings to both the researcher and REB and its decision on behalf of
the organization shall be final.
4. PROCEDURE
4.1. Within 60 days following the completion of the REB Reconsideration process, the
researcher must inform the Research Office of their request to appeal the REB
decision and submit the following documentation:
Page 3 of 5
(i)
(ii)
(iii)
Documentation demonstrating the efforts to resolve the matter through the
REB’s existing reconsideration processes (consultations, ad hoc meetings,
ongoing correspondence and communication);
A copy of the REB’s final decision letter; and
A document justifying the grounds on which the appeal is being requested
indicating any breaches of the research ethics review process or any
elements of the REB decision that are not supported by the TCPS2.
4.2. The Research Office will notify the REB of the request for appeal and request
information from the REB in relation to the decision(s) being appealed.
4.3. The REB will provide the Research Office with copies of all correspondence and other
supporting documents in relation to the decision(s) being appealed.
4.4. The Research Office will assess candidates for eligibility to serve on the Ad Hoc Appeal
Board and forward a listing of eligible candidates to the Board of Directors for
consideration.
4.5. The Board of Directors will establish the Ad Hoc Appeal Board from the eligible
candidate listing.
4.6. The Appeal Board will assess the request for appeal against the Eligibility Criteria for
Appeal.
4.7. If the request for appeal is deemed eligible, the Appeal Board will convene to discuss,
deliberate and vote on the matter.
4.8. If the request for appeal is deemed eligible, the Appeal Board will invite the researcher
and a representative of the REB to attend the Appeal Board meeting to address any
questions in relation to the decision(s) being appealed.
4.9. The Appeal Board will inform the researcher and REB of its decision in writing.
4.10.
If the request for appeal is denied, the Appeal Board will inform the researcher
and REB of its decision in writing
5. RESPONSIBILITY
Type of Policy
Policy Sponsor
Corporate
administrative
policies
Vice President
Quality, Research &
Innovation
Endorsing Authority
Research Office
Approval
Authority
Board of Directors
The Policy will be posted on the Hospital’s intranet site(s) and external website.
Page 4 of 5
7. RELATED POLICIES
III-8 Research - POL
8. APPROVED BY
2013/05/30
Board of Directors
Page 5 of 5
Part IV:
Financial and
Organizational
Viability
CATEGORY:
FINANCIAL AND ORGANIZATIONAL VIABILITY
POLICY #:
IV-1
SUBJECT:
FINANCIAL OBJECTIVES
The Board will ensure the safeguarding of the Corporation’s assets and the prudent use
of its resources. The Board will ensure that the Finance and Audit Committee, with the
CEO, annually develops key financial objectives for Board approval. The Board will
monitor performance against these objectives.
The Board will ensure that the Corporation is operated and managed in an efficient and
effective manner according to accepted business and financial practices and approved
policies, and that it operates within its known and approved annual funding and the
annual plan and Hospital Service Accountability Agreement.
The CEO is accountable to the Board for ensuring that this objective is achieved, that
the fiscal position of the Corporation is not placed at risk, and that adequate internal
controls and processes are in place, monitored for compliance, and regularly reviewed
by the Finance and Audit Committee as appropriate.
A material deviation of actual expenditures from Board approved priorities
and plan will not properly occur without prior Board approval; accordingly, the
CEO will not:
• direct or approve the expenditure of designated a n n u a l revenue for other
than its intended purpose;
• direct or approve the expenditure of more funds than have been budgeted, or
expend more funds than have been received or reasonably forecast to be
received;
• direct or approve the accumulation of debt for operational requirements in
an amount greater than provided within the approved working capital
plan;
• direct or approve the cash position falling, at any time, below the amount needed
to settle payroll and all other obligations in a timely manner, in accordance with
generally accepted good business practices or the agreed terms inherent with
the obligation; or
• knowingly allow any payments or filings to be overdue or inaccurately filed.
CATEGORY:
POLICY #:
IV-2
SUBJECT:
FINANCIAL PLANNING AND PERFORMANCE
The Board will review and approve the annual operating and capital budget. This budget
will become the basis for the Hospital Annual Planning Submission (HAPS) and the
Hospital Service Accountability Agreement (HSAA). The Corporation’s Hospital Service
Accountability Agreement with the LHIN will be approved by the Board and signed by the
Chair and the CEO, or other authorized signing officers on behalf of the Corporation by a
date in compliance with its requirements.
The Hospital Annual Planning Submission and operating plan will be aligned with the
Board’s established priorities, and will not place the Corporation at financial risk. The
Board will require that the annual operating plan and capital budget including working
capital will meet the Corporation’s needs as approved by the Board of Directors. The
CEO is responsible for preparing a draft Hospital Annual Planning Submission and a
draft operating plan and capital plan for each fiscal year. Before the Board grants its
approval of these documents, the Finance and Audit Committee will receive input from
Fiscal Advisory Committee and review and approve these documents for presentation to
the Board.
The Finance and Audit Committee will:
•
review and approve the Financial Planning Framework for hospital operations,
including establishing the time frame for planning; broad service distribution and
service targets, desired operating bottom-line; Ministry revenue assumptions; capital
financing direction; and desired cash flow position;
•
review and approve the detailed budget assumptions and rationale including
performance indicators required by the Ministry of Health and Long Term Care
and/or LHIN
•
review and recommend for Board consideration, the final operating plan on a timely
basis, ensuring broad planning parameters and detailed budget assumptions have
been utilized; and
•
regularly monitor actual performance against the approved operating plan to ensure
management complies with the operating plan and resources are being appropriately
reported.
The CEO will ensure that appropriate and effective administrative policies and
procedures exist to manage operating expenses within the annual budget, and that
these policies and procedures are monitored for compliance and reviewed annually by
the Finance and Audit Committee.
Financial stewardship for the Corporation will reflect:
•
financial resources are allocated annually according to the strategic priorities of the
Corporation;
•
the Corporation’s departments and units are responsible for cost-effective
operations of their functional areas, and exploring all opportunities for costcontainment, integration opportunities, savings and revenue-generation recognizing
that effective financial management is one aspect of the quality outcomes and
evaluation framework;
•
the Corporation will recognize the efforts of teams to generate innovative ideas and
reinvest efficiencies into strategic enhancements and the development of new
programs and services that fit within the strategic plan;
•
program shifts/enhancements will be supported by metrics analysis and an impact
analysis or business case, as appropriate;
•
all employees, professional staff members, contractors, students, board members
and volunteers act in a fiscally responsible manner, fulfilling their responsibilities for
stewardship of the resources entrusted to the Corporation, and appropriately
exercising the authority delegated to them; and
•
Appropriate analytical support will be provided to assist with development of the
impact analyses or business cases and monitoring of the plan.
The annual budget will contain sufficient information to provide:
i)
ii)
iii)
iv)
v)
vi)
vii)
viii)
a reasonable projection of revenues and expenses;
a separation of capital and operational items;
a cash flow analysis;
subsequent audit trails;
a borrowing requirements analysis;
disclosure of significant changes in financial position;
disclosure of all material planning assumptions; and
material changes to accounting treatment.
A deviation of actual expenditures from Board-approved priorities should not occur
without prior Board approval.
Monitoring of Financial Performance
At a minimum, on a quarterly basis, the Board, with the assistance of the Finance and
Audit Committee, will conduct a thorough assessment of the Corporation’s financial
performance employing a range of indicators.
Page 2 of 3
The CEO is responsible to ensure that the Corporation establishes and maintains
financial reporting systems in accordance with Canadian generally accepted accounting
principles and its accountability agreements and moving to Public Sector Accounting
Standards, with the not-for-profit accounting standards (Section 4200), effective April 1,
2012, as directed by the Ministry of Health and Long Term Care..
Subject to the above relevant basis of accounting, financial statements will be prepared
in conformance with the appropriate standards and will be presented to the Board and
Finance and Audit Committee for review at each meeting. The statements will include
performance indicators relevant to:
i)
financial position;
ii)
operations;
iii)
cash flows; and
iv)
covenants.
If the Board monitoring and assessment of these indicators identifies problems, the CEO
will be directed to devise and implement a plan to correct them. Such plans must be
submitted to and approved by the Finance and Audit Committee.
Capital Projects and Capital Planning
The CEO or designate will establish guidelines for the definition of capital equipment and
will annually review these guidelines and ensure that a process is in place to establish
multi-year capital plans for both equipment and facility investments and ensure an
annual capital project/plan and budget be developed, which will comprise part of the
annual operating plan approved by the Board. Yearly capital equipment budgets will be
recommended for Board approval based on prioritized submissions in accordance with
this policy. The capital budgeting process will be aligned with the requirements of the
Ministry’s Hospital Annual Planning Submission Guidelines. In addition, the Board may
consider approval of capital equipment/projects, as may be required outside of these
timelines, based on appropriate information. The Finance and Audit Committee will
review the capital plan and the Board will approve the plan as part of the Budget
Approval process.
Page 3 of 3
CATEGORY:
POLICY #:
IV-3
SUBJECT:
ASSET PROTECTION
The CEO is accountable to the Board to ensure that assets are reasonably protected,
adequately maintained and not placed at unnecessary risk. The CEO will ensure that
appropriate administrative policies and procedures are in place and that these policies
and procedures are monitored for compliance and reviewed annually by the Finance and
Audit Committee.
The CEO will ensure that:
i)
reasonable insurance against fire, theft and casualty losses, with an
appropriate deductible, is maintained;
ii)
there is appropriate property, boiler and machinery insurance coverage for all
assets owned by the Corporation, which may be subject to replacement or
repair as a result of theft or casualty loss;
iii)
there is an asset registry;
iv)
there is a program to ensure that plant, equipment and systems are well
maintained, in compliance with legal requirements, and are not subjected to
improper wear and tear, and that there is a proactive strategy in place to
replace and renew equipment as it ages, subject to the Board of Directors
approval of the working capital plan;
v)
adequate liability insurance coverage is maintained for the Corporation,
Directors and officers in order that they will be indemnified and saved
harmless while engaged in activities on behalf of the Corporation;
vi)
the Corporation insures to an appropriate extent against losses due to errors
and omissions on the part of Directors, officers or employees;
vii)
the Corporation, its Directors, officers and employees are not unnecessarily
exposed to liability claims;
viii)
there are appropriate and adequate financial internal controls for the receipt,
disbursement, and processing of funds and that these controls are reviewed
annually; Management will report any issues to the Finance and Audit
Committee;
ix)
financial reporting is consistent with Canadian Generally Accepted Accounting
Principles;
x)
unbonded/uninsured personnel do not have access to material amounts of
funds;
xi)
the Corporation is not knowingly endangered with regard to its public image or
credibility; and
xii)
only personnel approved within the Signing Authority policy will access funds
as appropriate.
Page 2 of 2
CATEGORY:
POLICY #:
IV-4
SUBJECT:
DELEGATION OF SIGNING AUTHORITY
The purpose of the Board of Directors Signing Authority is to designate the authority
levels for the President and Chief Executive Officer (CEO) and Directors. The CEO is
accountable to the Board to ensure that the Corporation has in place policies and rules
related to the Corporate Signing Authority.
The Corporate Signing Authority Policy provides the appropriate signing authority levels
for purchases of goods, non-consulting services, investments and construction within
HAPS and H-SAA, the Board of Directors authorizes the CEO to approve expenditures,
purchase orders, invoices, contracts, investment decisions and related instructions,
commitments etc. under $5 million. Until such time as one Corporate Signing Authority
Policy is adopted by The Credit Valley Hospital and Trillium Health Centre, the current
site specific Corporate Signing Authority policies will apply at each site.
In the absence of the President and CEO, the CEO can delegate the signing authority to
the Acting CEO who will approve expenditures under $5 million with the exception of
sole sourced or non-competitive consulting services.
The Corporate Signing Authority Policy directs the organization in conjunction with:
• Administrative policies.
• Internal budgeting policies that have been developed as part of the hospital’s
system of internal control. Those policies provide direction to hospital leaders for
developing and managing the hospital’s budgets.
The Governance Committee reviews the policy annually.
The Board identifies the designated Signing Officers of the corporation and their
authority.
Schedule I: Signing Officers
The following individuals are the designated signing officers of the Corporation:
Chair, Board of Directors
Vice Chair, Board of Directors
Treasurer, Board of Directors
President and CEO
Chief Financial Officer
Senior Executive Staff members so designated by the CEO and set forth in relevant
administrative policies.
Any two of the above must sign cheques, bills of exchange or other negotiable
instruments and orders for payment required for the day-to-day operation of the
corporation, which are specifically included in the budget approved by the Board, or
otherwise approved by the Board. This authority may not be delegated. One signatory
must be a signing officer listed above who is not an employee of the Corporation, in the
case of cheques, bills of exchange or other negotiable instruments in excess of
$5,000,000. An electronic signature may be used to automate the cheque signing
process, subject to appropriate safeguards.
In addition to the above, the Board may from time to time by resolution direct the manner
in which and the person or persons by whom any particular instrument or class of
instruments or document may or shall be signed. Any signing officer may affix the seal
of the Corporation to any instrument or document and may certify a copy of any
instrument, resolution, by-law or other document of the corporation to be a true copy.
The CEO is accountable to the Board for ensuring that adequate internal controls and
processes are in place.
Schedule II: Board Authorization
Prior Board approval is required for any of the following:
1. Taking or instituting proceedings for the winding-up, reorganization or dissolution
of the Corporation;
2. The enactment, ratification or amendment of any by-laws of the Corporation;
3. The sale, lease, exchange or other disposition of all or substantially all of the
assets or undertakings of the Corporation;
4. The mortgaging, pledging, charging or otherwise encumbering any of the assets
of the Corporation;
5. All real estate purchases and sales; and
6. All related budgets for new construction and building capital renovation costs
prior to any spending. After Board approval has been obtained, the CEO has
approval to authorize tender requests, contracts, contract amendments, changedirectives, change-orders, progress draws, purchase orders and invoices that
remain within the budget estimates. The CEO may designate such approval
which will be set forth in relevant administrative policies.
Page 2 of 2
CATEGORY:
POLICY #:
IV-5
SUBJECT:
BORROWING
In accordance with the Corporate By-law (Section 11.6), designated signing officers of
the Corporation may from time to time borrow money from a bank. Approval from the
Board, on recommendation from the Finance and Audit Committee, is required for the
Corporation to borrow money. Subject to the above, the Corporation may, from time to
time:
i)
borrow money on the credit of the Corporation;
ii)
issue, sell or pledge securities (including bonds, debentures, notes or other
similar obligations, secured or unsecured) of the Corporation; or
iii)
charge, mortgage, hypothecate or pledge all or any of the real or personal
property of the Corporation, including book debts and unpaid calls, rights and
powers, franchises and undertakings, to secure any securities or for any
money borrowed, or other debt, or any other obligation or liability of the
Corporation.
The Corporation will only borrow money for the following purposes:
i)
to secure bridge financing for working capital requirements;
ii)
to secure operating financing (line of credit) to fund normal operating
requirements arising from timing differences between cash inflows and
expenditures;
iii)
to secure capital project financing to support a capital project;
iv)
to lease or finance capital equipment that is part of the Corporation’s Boardapproved capital project plan;
v)
to lease or finance land or property consistent with the Corporation’s master
plan; or
vi)
to support an expenditure justified by a business case with an acceptable
financial return.
CATEGORY:
POLICY #:
IV-6
Draft Revised October 2012
Statement of Investment Policies and Procedures
Prepared For:
The Credit Valley Hospital and Trillium Health Centre
(hereinafter referred to as the “Hospital”)
Effective:
October 2012
This statement of Investment Policies and Procedures (hereinafter referred to as
the “Statement”) describes the investment objectives of the Hospital with respect
to its three categories of investment funds. These categories include the
Committed Projects Fund, The Superbuild Fund, and The Future Development
Fund (hereinafter referred to as the “Funds”). The basic goal of this Statement is
to assist The Finance and Audit Committee of the Board of Directors, in ensuring
that the assets of the Hospital, together with any subsequent contributions and
income, shall be invested in a prudent and effective manner.
Section 1 - Purpose of the Statement
The primary purpose of the Funds is to provide resources for the pursuit of the goals and
objectives of the Hospital. The prudent and effective management of the Funds has a
direct impact on the achievement of these goals and objectives and the Finance and Audit
Committee is responsible for ensuring that the Funds are manages in a prudent and
effective manner.
This Statement provides a set of written guidelines for managing the investments of the
Hospital. The Statement will be reviewed annually by the Finance and Audit committee
to ensure that it continues to reflect the Hospital’s requirements.
The general objectives of the Statement are to:
•
establish the investment objectives, policies, and guidelines relating to any
investment owned or controlled by the Hospital;
•
establish the different investment groups (currently: Committed Projects
Fund, Superbuild Fund and Future Development Fund) (the “Funds”);
•
identify the criteria against which the investment performance of the
Funds will be measured;
•
serve as a review document to guide the ongoing investment management
and oversight of the Funds.
Section 2 - Scope
In accordance with the Corporate By-law (Section 11.7), the board is authorized to make
or receive any investments, which the Board in its discretion considers advisable.
The Board may invest:
1. All monies given in trust to the Corporation for the use of the Corporation; and
2. All monies not required for operating expenses.
Section 3 – Allocation of Responsibilities
The Finance and Audit Committee oversees investment management of the Fund and is
responsible to report back to the Board. The Committee shall:
•
Establish the Statement of Investment Policies and Procedures;
Page 2 of 8
•
•
•
•
•
•
Ensure that members of the Finance and Audit Committee are in compliance
with all Conflict of Interest Provisions where it relates to investments of the
Hospital;
Select one or more Investment Manager(s) to manage the investment of the
Fund’s assets; and if required, one or more Custodian(s) to hold the Fund’s
assets. Management of any other assets may be carried out internally by
management, and unless specifically requested by the Board is not governed
by this Statement;
At least annually:
o Review, amend where necessary, and approve this Statement and
record such proceeding and decisions in the minutes of the Finance
and Audit Committee. This review will be done having regard to the
following:
 General economic conditions.
 The possible effect of inflation or deflation.
 The role that each asset class plays within the Funds and their
respective objectives;
 The expected total return from income and the appreciation of
capital;
 Needs for liquidity, regularity of income and preservation or
appreciation of capital;
 An assets special relationship or special value, if any, to the
purpose of the Funds.
o confirm the applicability of the underlying investment categories, The
Committed Projects Fund, The Superbuild Fund and The Future
Development Fund and review their individual performance objectives
in conjunction with the short and long term cash/capital requirements
of the Hospital by fiscal year;
o confirm the applicability of any pooled fund investments to ensure
suitability to the Funds;
o oversee the performance relative to the performance objectives and
make recommendations to the Board as to the selection, engagement
or dismissal of an investment manager (the “Investment Manager”)
to manage the Funds;
o meet with a representative of the Investment Manager to discuss
investment performance and the Statement.
At least semi-annually:
o review the performance of the Investment Manager, and the Funds
relative to the performance objectives;
At least quarterly:
o review the financial performance of the Funds and compliance with
the Statement.
Maintain an understanding of any legal and regulatory requirements, and
constraints that may apply to the Hospital’s investments.
Page 3 of 8
•
Be responsible for delegation of any responsibilities not specifically
mentioned in this Statement;
•
Enter into contracts with the Investment Manager(s) and, if required,
Custodian(s) mentioned above on a basis that may be terminable within 30
days;
•
It is expected that the Hospital will have some pooled fund investments,
which offer lower costs and sufficient diversification but are governed by the
general investment policies of each fund as set by the Investment Manager.
Any such policies need to be accepted by the Finance & Audit Committee
prior to investment (dated, signed and kept on file at the Hospital).
•
The Hospital will regularly monitor all transactions performed by the
Custodian and shall have access to direct electronic interchange to perform the
monitoring.
The Investment Manager(s) shall be required to:
•
•
•
•
Invest the assets of the Funds in accordance with this Statement;
Notify the Hospital in writing of any significant changes in the investment
manager’s philosophies and policies, personnel or organization and
procedures;
Meet with the Hospital representatives as required and provide required
reporting;
For pooled and mutual funds, the investment manager will ensure custodial
services are performed by a reputable third party provider; Manage the Funds
with the care, diligence and skill that a prudent person skilled as a professional
investment manager would use in dealing with Institutional assets.
The Custodian(s) shall be required to:
•
•
•
Fulfill the regular duties required by law of the Custodian in accordance with
the Funds;
Provide management of the Hospital with periodic portfolio reconciliations
and performance reports as required of all Fund assets and transactions during
the period; and
Provide other services from time to time as may be mutually agreed with
management of the Hospital and/or the Board.
Section 4 - Investment Objectives
The assets of the Funds are to be managed with the primary objective of providing
resources for the pursuit of the goals and objectives of the Hospital.
Page 4 of 8
The investment objectives of the Hospital are:
1. The preservation and enhancement of capital through adequate diversification
of high quality investments;
2. The achievement of the highest investment return that can be obtained with
assumption of an acceptable degree of risk;
3. The exercise of the care, skill, diligence and judgment of a prudent investor;
4. Compliance with the Trustee Act; and
5. The Hospital will not invest in securities of corporations involved in the
production, manufacture or sale of tobacco products.
Investment activities are to be undertaken in a manner designed primarily to preserve and
enhance capital, and secondarily to optimize investment yield having regard to
permissible investments. In all respects; maturity dates of investments will recognize the
forecasted cash flow requirements of the Corporation.
Section 5 – Investment Groups that Make-up the Fund & Return Expectations
There are three categories of accounts that make up the Funds. Each category has distinct
needs managed for the Hospital.
Committed Projects Fund:
This fund was established to hold investments where the
proceeds were designated for use in approved capital
projects that were pending and in development.
Superbuild Fund:
This fund was established to hold monies held in trust for
projects approved by Superbuild, now known as
Infrastructure Ontario.
Future Development Fund:
This fund was established to group many smaller
individually designated funds which have specific
purposes. Generally, all the individual funds within this
portfolio are endowments where income generated is
directed towards specific purposes.
Page 5 of 8
Committed Projects
Fund
Superbuild Fund
Future
Development
Fund
Income from
endowment funds
used to offset
ongoing operating
expenditures.
Spending
Policy
As needed for the
payment of
approved capital
projects.
As requested to be
applied against
future
Superbuild/IO
projects or
refunded to
Ministry.
Time Horizon
Short term
Less than 5 years on
a rolling basis
Less than 5 years on
a rolling basis
Short term
(< 1 year)
Long term
(>15 years)
Mostly liquid
Very low liquidity
requirements on
principle amounts
of the endowment
 Low
 Minimal risk
Liquidity
Risk Tolerance*
Return
Requirement


Low
0% tolerance
to risk


Low
0% tolerance
to risk
Commensurate
Net long term
with 91 Day T-Bill
return goal is to
achieve a minimum
return of the rate of
inflation (CPI) over
4-year rolling
periods to maintain
the real value of
the capital.
Net long term
return goal is to
achieve a minimum
return of the rate of
inflation (CPI) over
4-year rolling
periods to maintain
the real value of
the capital.
Tax
Not applicable as the Hospital is a registered charity
Legal
The Hospital is a registered charity
* Investments should be structured and managed to provide for the generation of the targeted
rate of investment return while assuming only the minimum, necessary amount of risk. Risk
will be measured in terms of the downside risk (or risk of loss) of the investment. As
appropriate, investments will maintain minimum levels of diversification in order to reduce
overall risk which may include diversification by asset class, industry sector and geography.
Page 6 of 8
Section 6 – Asset Mix
Asset allocation or mix refers to the allocation of funds among the major asset
classes, including but not limited to, cash, domestic bonds, and domestic and
international equities. Since the asset mix of a fund tends to determine its risk
and return characteristics, control of the fund’s asset mix is the Hospital’s
principal means of defining the Fund’s risk and return parameters. Asset classes,
allocation targets and permissible ranges are detailed in the attached Instructions
to Investment Manager(s).
Section 7 - Performance Evaluation Benchmarks
The benchmark can be thought of as representing a theoretical passive alternative to
active management. The various asset classes and benchmarks are as follows:
Asset Class
Money Market
Canadian Short-term Bonds
Canadian Mid-term Bonds
Canadian Bonds
Canadian Equities
Foreign Equities
Comparable Benchmark Index
DEX 91-day T-Bill index
DEX Short-term Bond index
DEX Mid-term Bond index
DEX Universe Bond index
S&P/TSX index
MSCI World index (Cdn$)
A portfolio benchmark return can be calculated using the neutral weighting of the above
noted indices and should be included with the Investment Manager’s quarterly reporting.
This equation will be used as a basis for comparison to the total return of the entire
portfolio. Portfolio return should be calculated on a Time Weighted basis and should
include realized and unrealized gains as well as income from all sources. Measurement
against performance objectives will normally be assessed over rolling four-year period.
Investment Manager Review Process
While the importance of due diligence implemented during the manager selection process
cannot be understated, the ongoing review and analysis of money managers is just as
important. Accordingly, a thorough review and analysis of the investment manager and
performance will be conducted, specifically if:
•
Overall compliance with the Investment Policy Statement guidelines is in
question;
•
A manager performs significantly below the agreed upon benchmark return gross
Page 7 of 8
of fees over a four year rolling average;
•
Significant short-term loss;
•
Perceived negligence.
Major organizational changes also warrant immediate review of the manager, including:
•
Change in professionals (research, analysis and partners);
•
Account losses in excess of the stipulated risk tolerance constraints;
•
Significant growth of new business;
•
Change in ownership;
•
Perceived negligence.
Servicing Requirements
•
Monthly statements from the Investment Managers;
•
Quarterly review meeting with the Finance and Audit committee and perhaps the
Board;
•
Monthly holdings and transaction report;
•
Quarterly reporting including compliance report.
Page 8 of 8
CATEGORY:
POLICY #:
IV-7
SUBJECT:
ENVIRONMENTAL PROTECTION
To define the Environmental Policy for Trillium Health Partners.
The environmental management system scope is as follows: A hospital providing
thirteen medical programs: Anesthesia, Diagnostic Imaging, Emergency Medicine,
Primary Care, Complex Continuing Care, Rehab, and Senior’s Services, Cardiac Health,
Laboratory Medicine, Medicine, Mental Health, Neurosciences/Muscular-Skeletal
Services, Oncology, Surgery, Women’s Health and Children’s Health. Related activities
include but are not limited to: Corporate Services (Housekeeping, Facilities
Maintenance, Waste Management and Materials Management) and Emergency
Management.
2. BACKGROUND
In accordance with Trillium Health Partners Strategic Plan, environmental sustainability
is supported through the implementation of an environmental management system.
In order to deliver on our “vision for a healthier community based on a complete system
of care” we recognize the potential environmental impact of our operations; and
subsequent potential effect on patients, staff, and the community.
An environmental management system manages risk by providing a systematic process
to meet legal requirements and to set objectives and targets to improve environmental
performance and patient care by reducing costs and developing process efficiencies and
operational controls.
By incorporating green conservation into our day-to-day roles we can contribute to the
efficient use of resources, which in turn can be reallocated to patient care.
In accordance with the ISO14001 standard, this Environmental Protection Policy
document is required to support the ISO14001 multi-site registration. ISO 14001 is an
international standard for environmental management systems. The Mississauga
Hospital and Queensway Health Centre have maintained this multi-site registration since
2004.
3. GUIDING PRINCIPLES
Trillium Health Partners complies with all relevant laws, regulations and maintains an
environmental management system.
4. POLICY
Trillium Health Partners is dedicated to green conservation in our day-to-day roles to
contribute to the efficient use of resources, which in turn can be reallocated to patient
care and protecting the environment, this includes:









implementing best management practices, procedures, and technology to avoid or
reduce pollution resulting from hospital operations;
promoting the purchasing and/or use of materials or products that consist of recycled
and/or reused materials or products, and considering the impacts of those materials
and products energy consumption, water utilization, waste generation and hazardous
material management;
complying with relevant environmental regulations, standards and codes of practice
and with other requirements to which THP subscribes which relate to its
environmental aspects;
conserving energy through efficient use and operation;
working to identify acceptable alternatives to hazardous materials and managing
those we continue to use in a manner that will reduce potential impacts;
minimizing waste generated by our operations and recycling wastes where
practicable;
monitoring the natural environment and our discharges to the environment to
understand better our environmental impacts and tracking progress toward achieving
objectives and targets;
maintaining open communication with staff, community, and other interested parties;
continually improving environmental performance through environmental audits,
participation in hospital industry associations, consultation with interested parties and
management reviews.
5. RESPONSIBILITY
Type of Policy
Corporate
administrative
policies
Policy Sponsor
Vice President,
Capital Planning,
Redevelopment
and Corporate
Services
Page 2 of 3
Endorsing
Authority
Priorities and
Planning Committee
Approval
Authority
Board of
Directors
The policy will be included in the Annual Mandatory Environmental Awareness Training
through the Learning Management System (LMS) to maintain awareness of the
environmental policy and programs.
7. REFERENCES AND ACKNOWLEDGEMENTS
Environmental Management System Documentation – PRO
Environmental Management System Resources; Roles; Responsibility and AuthorityPRO
8. RELATED POLICIES
Emergency Management – POL INT
9. APPROVED BY
2013-09
2013-09
Risk Management Committee
Governance Committee
10. SUPERSEDES
2006-03
2011-04
2008-05
Environmental Management Pol A5-4 (CVH version)
Board of Directors Environmental Protection Policy (THC version)
Board of Directors Environmental Protection Principle - 3700
11. APPENDICES
APPENDIX A – DEFINITIONS AND ACRONYMS
Environmental Policy: overall intentions and direction of an organization related to its
environmental performance as formally expressed by top management.
EMS: Environmental Management System
Page 3 of 3
Part V-A:
Governance
Policy Framework
CATEGORY:
BOARD EFFECTIVENESS
Part A: Governance Policy Framework
POLICY #:
V-A-1
SUBJECT:
PRINCIPLES OF GOVERNANCE AND BOARD
ACCOUNTABILITY
1.
The Corporation is one hospital corporation operating three interdependent sites.
2.
The Board governs the Corporation through the direction and supervision of the
business and affairs of the Corporation in accordance with its Articles of
Amalgamation, its by-laws, vision, mission and core values, governance policies
and applicable laws and regulations.
3.
The Board adheres to a model of governance through which it provides strategic
leadership and direction to the Corporation by establishing policies, making
governance decisions, monitoring performance related to the key dimensions of the
Corporation’s mission, as well as evaluating its own effectiveness and by building
system relationships.
4.
The Board acts at all times in the best interests of the Corporation, having regard for
its accountabilities to its patients and the community served, to the Government of
Ontario (Government) and the Mississauga Halton Local Health Integration Network
(LHIN) and its relationship with other service providers.
5.
The Board maintains a culture based on the values as approved by the Board and
strives for a collaborative approach to decision-making, based on evidence, best
practice, open debate and a forthright examination of all issues while respecting and
valuing dissenting views.
6.
The Board maintains at all times a clear distinction between the governance and
operation of the Corporation, while recognizing the interdependencies between
them.
7.
The Board is accountable to:

the Corporation’s patients and its communities served for:

the quality of the care, treatment and safety of patients;

engaging the communities served when developing plans and setting
priorities for the delivery of health care;


operating in a fiscally sustainable manner within its resource envelope
and utilizing its resources efficiently and effectively across the spectrum
of care to fulfill the Corporation’s mission and mandate;

advocating for and seeking resources to provide appropriate health care;

the appropriate use of community contributions and resources;

considering the diversity of needs and interests in its policy formulation
and decision-making;
the Government for:


the LHIN for:

8.
compliance with applicable laws and regulations, policies and directions
and implementation of approved capital projects;
ensuring that the Corporation operates in a manner that is consistent
with:

the LHIN’s integrated health service plan;

the Hospital Service Accountability Agreement with the LHIN.
Consistent with the Board’s commitment to good governance practices, timely
access to information, appropriate protection of personal privacy, and appropriate
protection of other information that is exempt or excluded from disclosure under the
Freedom of Information and Protection of Privacy Act, the Board will make available
to the public:

the statement of Board and Director roles, responsibilities and
accountabilities;

a list of elected and ex-officio Directors and their attendance records;

policies governing the Board and Board standing committees;

a report on the Corporation’s performance as part of the Corporation’s Annual
Report;

the Corporation’s Quality Improvement Plan, in compliance with the Excellent
Care for All Act, 2010;

information about expense claims in compliance with any directives made
under the Broader Public Sector Accountability Act, 2010; and

upon request, information that is subject to disclosure under the Freedom of
Information and Protection of Privacy Act.
Page 2 of 2
CATEGORY:
BOARD EFFECTIVENESS
Part A: Governance Policy Framework
POLICY #:
V-A-2
SUBJECT:
ROLES AND RESPONSIBILITIES OF THE BOARD OF
DIRECTORS
The Board governs by fulfilling the following roles:
Policy Formulation
Establish policies to provide guidance to those empowered with the responsibility to
lead and manage operations.
Decision-Making
On matters that specifically require Board approval, choose from alternatives that are
consistent with Board policies and that are in the best interest of the Corporation.
Oversight
Monitor and assess organizational processes and outcomes.
Responsibilities of the Board
Strategic Direction
• Consider key stakeholders and health care needs and engage with the community
served, the LHIN and other health service providers when developing plans and
setting priorities for the delivery of health care as required under the Local Health
System Integration Act;
• Establish and periodically review the Corporation’s mission, vision and core values;
• Contribute to the development of and approve the strategic plan of the Corporation,
ensuring that it is aligned with community need, Ministry policy, the LHIN integrated
health services plan and promotes where appropriate integration with other health
service providers;
• Conduct a review of the strategic plan as part of a regular annual planning cycle;
• Ensure that the Board’s decisions are consistent with government policy, the LHIN’s
integrated health service plan, and the Corporation’s mission, vision, core values and
strategic plan; and
• Monitor and measure corporate performance regularly against the approved strategic
plan and Board approved performance indicators.
Excellent Management
• Select and appoint the CEO;
• Establish measurable annual performance expectations in co-operation with the CEO;
assess CEO performance annually and determine compensation;
• Delegate responsibility and authority to the CEO for the management and operation
of the Corporation and require accountability to the Board;
• Select and appoint the Chief of Staff;
• Establish measurable annual performance expectations in co-operation with the Chief
of Staff; assess Chief of Staff performance annually and determine compensation;
• Delegate responsibility and authority to the Chief of Staff for the supervision of the
practice of medicine, dentistry, midwifery and extended class nursing in the
Corporation and require accountability to the Board;
• Approve the plans for CEO and Chief of Staff succession;
• Review and approve the CEO’s and Chief of Staff’s succession plans for the senior
management team and clinical chiefs, including executive development;
• Appoint department chiefs and other medical leadership positions, on the
recommendation of the Chief of Staff, as required under the Corporation’s
Professional Staff By-law and the Public Hospitals Act; and
• Establish and monitor implementation of policies to provide the framework for the
management and operation of the Corporation in compliance with applicable laws and
regulations.
Program Quality and Effectiveness
• Review and approve the Chief of Staff’s human resources plan for the Professional
Staff annually;
• Review the credentialing process for the Professional Staff annually and be assured
by the Chief of Staff as to the effectiveness and fairness of this process;
Page 2 of 5
• Approve appointments, reappointment and privileges for Professional Staff based on
the human resources plan and review of recommendations by the Medical Advisory
Committee;
• Provide oversight of the credentialed Professional Staff through the Chief of Staff, and
the Medical Advisory Committee and if necessary or advisable, effect the restriction,
suspension or revocation of privileges of any credentialed Professional Staff member
as provided under the Public Hospitals Act and the Professional Staff By-law;
• Review and approve the Quality Improvement Plan and approve a process and
schedule for monitoring Board-approved performance metrics related to quality of
care, patient safety and organizational risk;
• Ensure that policies are in place to provide a framework for addressing ethical issues
arising from care, education and research in the Corporation; and
• Receive timely reports from the CEO and Chief of Staff on plans to address variances
from performance standards, and oversee implementation of the remediation plans.
Financial and Organizational Viability
• Review and approve the Hospital Annual Planning Submission including the capital
and operating budget; approve the Hospital Services Accountability Agreement and
monitor financial performance against the budget and performance indicators;
• Review and approve the multi-year financial plans and operate within the Hospital
Services Accountability Agreement;
• Review financial and organizational risks and risk mitigation plans regularly;
• Approve an investment policy and monitor compliance;
• Review the financial reporting process, management information systems, internal
controls and business continuity plans annually;
• Ensure policies are in place on asset protection, purchases, contracts, leases,
borrowing and signing authority; and
• Review quarterly financial reports and approve the annual audited financial
statement.
Board Effectiveness
• Recruit Directors and where appropriate Non-Director members of committees, who
are skilled, experienced, reflective of the communities we serve and committed to the
Corporation and plan for the succession of Directors and Board Officers;
• Establish a comprehensive Board orientation program and ongoing Board education;
Page 3 of 5
• Establish Board goals and an annual work plan for the Board and its committees and
ensure that the Board receives timely appropriate information to support informed
policy formulation, decision-making and monitoring;
• Establish and periodically review policies concerning governance structures and
processes to maximize the effective functioning of the Board;
• Establish a policy and process for evaluating the performance of the Board as a
whole and of individual Directors that fosters continuous improvement.
External Relationships
•
Ensure that the Corporation builds and maintains good relationships with the Ministry
of Health and Long Term Care and other government Ministries in fulfilling its
obligations under provincial policies and with the LHIN in fulfilling the Corporation’s
Hospital Services Accountability Agreement;
•
Ensure that the Corporation is filling its role as a regional resource and referral centre
within the LHIN region by fostering effective coordination of patient care and positive
working relationships with other hospitals and community health care providers;
•
Ensure that the Corporation builds and maintains good relationships with the
University of Toronto Mississauga and other educational institutions in fulfilling its
mission as a community affiliate of the University of Toronto Faculty of Medicine;
•
Ensure that mechanisms are in place for effective two-way communication within the
Corporation with Professional Staff, staff, volunteers, foundations and with its
members, community stakeholders, including elected officials and political leaders,
the media, donors, and the broader public.
Support and Relationships with the Foundations
Strong and positive relationships between the Corporation and the foundations are
essential at several levels:

The Board will support the foundations in their endeavours.

Individual Directors are expected to support the foundations, and are encouraged to
contribute financially to the foundations in their fundraising efforts.

Regular communications will be essential and achieved through a number of
mechanisms, such as:
o
a semi-annual meeting between designated representatives of the Board and
the foundations’ boards of directors to review strategic priorities, fundraising
needs and areas for collaboration and alignment of fundraising initiatives;
Page 4 of 5
o
the foundation chairs will be asked to present brief annual reports at the
annual meeting; and
o
regular meetings between the CEO and the CEOs of the foundations will be
scheduled related to capital equipment priorities and operational matters
related to allocation of the foundations’ donations to the Corporation.
Page 5 of 5
CATEGORY:
BOARD EFFECTIVENESS
Article A: Governance Policy Framework
POLICY #:
V-A-3
SUBJECT:
RESPONSIBILITIES AS AN ELECTED AND EX-OFFICIO
DIRECTOR
The following is a statement of responsibilities for both elected and ex-officio Directors,
which should also be understood as the Board of Directors Code of Conduct. The legal
expectations of ex-officio Directors are the same as those expected of elected Directors.
Exceptions to Board process requirements for ex-officio Directors are noted. All
Directors will complete a Director’s Declaration of commitment to and compliance with
these responsibilities annually.
Fiduciary Duty and Duty of Care
As a fiduciary of the Corporation, a Director acts ethically, honestly, and in good faith
with a view to the best interests of the Corporation and in so doing, supports the
Corporation in fulfilling its mission and discharging its accountabilities. A Director
exercises the care, diligence and skill that a reasonably prudent person would exercise
in comparable circumstances. Directors with special skill and knowledge are expected to
apply that skill and knowledge to matters that come before the Board.
A Director does not represent the specific interests of any constituency or group. A
Director acts and makes decisions that are in the best interest of the Corporation as a
whole. A Director commits to the vision, mission and core values of the Corporation and
complies with the Public Hospitals Act, the Corporations Act, other applicable laws and
regulations, the Corporation’s Articles of Amalgamation and by-laws, and Board policies.
Exercise of Authority
A Director carries out the powers of office only when acting as a member during a duly
constituted meeting of the Board or one of its committees. A Director respects the
responsibilities delegated by the Board to the CEO and Chief of Staff, avoiding
interference with their duties but insisting upon accountability to the Board and reporting
mechanisms for assessing organizational performance.
Conflict of Interest
A Director does not place him/herself in a position where his/her personal interests
conflict with those of the Corporation. A Director complies with the Conflict of Interest
provisions in Section 6.1 of the Corporate By-law and the Board Policy Manual.
Team Work
A Director maintains effective relationships with Directors, management and
stakeholders by working positively, cooperatively and respectfully with others in the
performance of his/her duties while exercising independence in decision making.
Participation
A Director expects to receive relevant information in advance of the meetings and
reviews pre-circulated material and comes prepared to Board and committee meetings
and educational events, asks informed questions, and makes a constructive contribution
to discussions. A Director considers the need for independent advice to the Board on
major corporate actions.
Formal Dissent
A Director reviews the minutes of the previous meeting on receipt and insists that they
record any Director’s disclosure, abstinence or dissent. A Director who is absent from a
Board meeting is deemed to have supported the decisions and policies of the Board
taken in his/her absence unless he or she formally records a dissenting view with the
Board secretary. While an absent Director may formally record a dissenting view at the
next meeting at which the Director is in attendance, this does not change the decision
reached by the Board.
Board Solidarity
The official spokesperson for the Board is the Chair or the Chair’s designate. A Director
supports the decisions and policies of the Board in discussions with outsiders, even if
the Director holds another view or voiced another view during a Board discussion or was
absent from the Board meeting. A Director refers requests for statements on behalf of
the Board to the Chair.
Confidentiality
Every Director shall respect the confidentiality of the information of the Corporation,
including matters brought before the Board and all committees, keeping in mind that
unauthorized disclosure of information could adversely affect the interests of the
Corporation.
Time and Commitment
A Director is generally expected to commit the necessary time required to fulfill Board
and committee responsibilities including preparation for and attendance at Board
meetings, assigned committee meetings and events.
A Director is expected to attend a minimum of 80% of the meetings of the Board and
80% of committee meetings of which he/she is a member in person or by electronic
means. Directors who fail to meet the attendance requirements are subject to review by
the Chair and may be asked to step down from the Board. All Directors are expected to
Page 2 of 3
serve on at least one Board committee and to represent the Board and the Corporation
in the community when requested by the Chair.
Skills, Expertise and Essential Competencies
A Director actively contributes specific skills and expertise and possesses the following
essential competencies and qualities which are necessary for all Directors to fulfill their
responsibilities:
• personal and professional integrity, wisdom and judgment;
• a commitment to ethical standards and behaviour;
• experience in and understanding of governance including the roles and
responsibilities of the Board and individual Directors and the difference between
governance and management;
• ability to participate assertively and communicate effectively as a member of the team
with other members of the Board and senior management;
• ability to think critically and ask relevant questions at a strategic level.
Education
A Director seeks opportunities to be educated and informed about the Board and the key
issues in the Corporation and broader health care system through review of the Board
Orientation Manual, participation in Board orientation and ongoing Board education.
Evaluation and Continuous Improvement
A Director is committed to a process of continuous self-improvement as a Director. All
Directors participate in evaluation of the Board and elected Directors participate in
individual Director peer assessment and act upon results in a positive and constructive
manner.
Fundraising Activity
A Director supports the fundraising activities of the foundations.
Page 3 of 3
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-A-4
SUBJECT:
DIRECTOR’S DECLARATION
A Director of the Corporation acknowledges and accepts that the Board of Directors is
accountable to:
•
its patients and communities served for:
•
the quality of the care, treatment and safety of patients;
•
engaging the communities served when developing plans and setting
priorities for the delivery of health care;
•
operating in a fiscally sustainable manner within its resource envelope and
utilizing its resources efficiently and effectively across the spectrum of care to
fulfill the Corporation’s mission and mandate;
•
advocating for and seeking resources to provide appropriate health care;
•
the appropriate use of community contributions and resources;
•
considering the diversity of needs and interests in its policy formulation and
decision-making;
• the Government of Ontario for:
•
compliance with applicable laws and regulations, policies and directions
and implementation of approved capital projects;
• the Mississauga-Halton LHIN for:
•
ensuring that the Corporation operates in a manner that is consistent
with:

the LHIN’s integrated health service plan; and

the Hospital Service Accountability Agreement with the LHIN.
I have complied in the past and agree to comply in the future with the performance
expectations as stated in the appended document Responsibilities as an Elected and
Ex-Officio Director.
As a Director, I confirm that I do not have a conflict of interest which would prevent me
from serving as a Director pursuant to the Conflict of Interest provisions in Section 6.1 of
the Corporate By-law and in the Board Policy Manual.
I hereby consent to act as a Director of the Corporation. I also hereby consent pursuant
to the provisions of Section 5.3 of the Corporate By-law to the holding of meetings of the
Board of Directors or of any committee of the Board of Directors by means of such
telephone, electronic or other communication facilities as permit all persons participating
in the meeting to communicate with each other simultaneously and instantaneously.
These consents will continue in effect from year to year so long as I am a Director. I
agree to abide by the confidentiality provisions in the Corporate By-law, Board Policy
Manual and in the Corporation’s privacy policies.
I undertake to advise the Corporation in writing of any change of address as soon as
possible after such change.
Dated: ______________________________________
Signature:
______________________________________
Print Name: ______________________________________
Address:
______________________________________
______________________________________
Page 2 of 2
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-A-5
SUBJECT:
GUIDELINES FOR THE SELECTION OF DIRECTORS
Balance within the Board
• The Board as a whole should be seen by the community it serves, government and
the broader community as capable, experienced and well able to govern the
organization; and
• The membership of the Board and its committees should be drawn widely to achieve
a balance of skills and expertise needed for the Board to fulfill its governance roles
and responsibilities and to genuinely reflect the breadth, depth and diversity of the
community it serves so it can maintain the confidence of all it serves.
Board Skills and Expertise
While the Board will give priority to recruitment of different skills, expertise and
experience over time, the Directors should collectively possess a range of specific skills,
expertise and experience from among the following:
•
audit, accounting and finance;
•
senior level business leadership in a complex corporate environment
•
governance;
•
strategic planning;
•
community leadership;
•
construction, project management (may be a time-limited requirement);
•
information systems management/technology;
•
marketing, communications and media/public relations;
•
quality, risk management and performance measurement;
•
law;
•
government relations
•
public policy and research;
•
knowledge of health care systems;
•
human resource management; and
•
health education.
Director Qualities and Competencies
Beyond the range of skills and expertise identified above, the essential competencies
and qualities that are necessary for all Directors to fulfill their responsibilities include:
•
experience in and understanding of governance including the roles and
responsibilities of the Board and individual Directors and the difference between
governance and management;
•
personal and professional integrity, wisdom and judgment;
•
a commitment to ethical standards and behaviour;
•
an ability to work and communicate effectively as a member of the team with
other Directors and senior management; and
•
ability to think critically and ask relevant questions at a strategic level.
As defined in the Corporate By-law (Article 4 Section 4.4), no person shall be qualified
for election or appointment as a Director if he or she:
a) is less than 18 years of age;
b) has the status of a bankrupt;
c) except as required by the Public Hospitals Act, is a current employee of the
Corporation or Professional Staff member.
Page 2 of 2
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-A-6
SUBJECT:
BOARD SIZE AND COMPOSITION
In accordance with the Corporate By-law (Article 4 Section 4.1), the Board will consist of:
a)
the following elected Directors:
i)
until the annual Members’ meeting in 2013, 14 elected Directors;
ii)
from the annual Members’ meeting in 2013 until the annual Members’
meeting in 2014, 13 elected Directors; and
iii)
from the annual Members’ meeting on 2014 until the annual Members’
meeting in 2015 (and thereafter, unless otherwise specifically provided
by the Corporation By-law), 12 Directors,
who satisfy the criteria set out in Section 4.3 of the Corporate By-law and who
are elected by the Members in accordance with Section 4.8 of the Corporate Bylaw or appointed in accordance with Section 4.10 of the Corporate By-law; and
b)
the following six ex-officio non-voting Directors:
i)
the CEO;
ii)
the Chief of Staff;
iii)
the President of the Professional Staff;
iv)
the Vice President of the Professional Staff;
v)
the Chief Nursing Executive; and
vi)
the Dean of Medicine of the University of Toronto or a designate.
In accordance with the Corporate By-law (Article 4 Section 4.9), each Director shall be
eligible for re-election provided that such Director shall not be elected or appointed for a
term that will result in the Director serving more than nine consecutive years. In
determining a Director's length of service as a Director, service prior to the coming into
force of the Corporate By-law at The Credit Valley Hospital or at Trillium Health Centre
shall be excluded. Despite the foregoing a Director may, by Board resolution, have
his/her maximum term as a Director extended for the sole purpose of that Director
succeeding to the office of Chair or serving as Chair. Despite the foregoing, where a
Director was appointed to fill an unexpired term of a Director, the partial term shall be
excluded from the calculation of the maximum years of service.
The Directors of the Corporation will be entitled to serve a maximum of nine years,
normally based on three, three-year terms. However, to achieve the staggering of terms
required by the Corporations Act and the Public Hospitals Act, each of the 14 initial
elected Directors will be assigned an initial term of one, two or three years reflecting
Director preference where possible.
Page 2 of 2
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-A-7
SUBJECT:
BOARD STANDING COMMITTEE PRINCIPLES
As per the Corporate By-law (Article 8), the Board may establish committees from time
to time. The Board shall determine the duties of such committees. The Board
committees shall be:
• Board Standing Committees, being those committees whose duties are normally
continuous; and
• Special Committees, being those committees appointed for specific duties whose
mandate shall expire with the completion of the tasks assigned.
The Board may establish a committee to function as an executive committee and may
delegate to such committee any powers of the Board, subject to such restrictions, as
may be imposed by the Board by resolution.
This Policy is intended to supplement the By-law provisions.
Board Standing Committees
The following Board Standing Committees will be established:
•
Finance and Audit Committee;
•
Governance and Human Resources Committee;
•
Quality and Program Effectiveness Committee;
•
Priorities and Planning Committee; and
•
Medical Advisory Committee.
If a committee is to function as an executive committee, the Terms of Reference of such
a committee will so provide.
Board Standing Committee Principles
a) Relationship between the Board and Board Standing Committees
i)
The Board will approve Terms of Reference and membership of the Board
committees annually on the recommendation of the Governance and Human
Resources Committee as soon as possible following the annual meeting..
ii) The Board will monitor the performance of its Board committees at each regular
Board meeting through minutes or a summary written report and a verbal report
by the committee chair related to specific recommendations of the Board
committee for approval by the Board.
iii) The Terms of Reference for Board committees will be reviewed annually by the
respective committee, which will make recommendations to the Governance and
Human Resources Committee and thereafter to the Board for approval as
appropriate.
iv) Board committees may not speak or act for the Board except when formally
given such authority for specific and time-limited purposes. Such delegation will
be framed so as to not conflict with the authority delegated to the CEO.
v) Unless otherwise specified, Board committees may not commit or bind the
Corporation to any course of action and no decision of a committee is binding on
the Board until approved or ratified by the Board.
vi) Unless otherwise authorized to do so, a Board committee may not engage
independent legal counsel or consulting advice without prior Board approval.
vii) The Chair, Vice-Chair, or CEO may, at any time, call a special meeting of a
Board Standing Committee.
b) Mandate of Board Standing Committees
i)
The number and type of committees should support the Board in fulfilling its
defined responsibilities and maximizing the participation of individual Directors.
ii) The Board as a whole is responsible and accountable for the work that is done
on its behalf by committees, task groups, etc.
iii) The mandate for each Board Standing Committee including the function of the
executive committee, is outlined in a Terms of Reference. Terms of Reference
for the Medical Advisory Committee are set out in the Professional Staff By-Law.
iv) Board Standing Committees should establish annual goals, work plans and work
products for Board approval.
v) The Board, through the Governance and Human Resources Committee should
conduct a periodic review of Board Standing and Special Committees to ensure
the continuing relevance of their mandate and membership.
c) Membership
i)
The responsibility for Board Standing Committee participation should be
balanced among all Directors.
ii) All Directors (including ex-officio Directors) should be expected to serve on at
least one Board Standing Committee.
iii) Subject to specific exceptions by the Board, or in accordance with law, the
majority of Board Standing Committee members should be elected Directors.
iv) Subject to the approval by the Board, non-Directors (community members) may
be appointed to serve on designated Board Standing Committees.
v) Board Standing Committee Terms of Reference should specify a defined number
of members including both elected and ex-officio Directors and additional nonDirector (community) members as appropriate.
vi) The Chair, Vice-Chair and members of Board Standing Committees are
appointed annually by the Board on the recommendation of the Governance and
Human Resources Committee, following a canvas of Directors for their interests
and preferences.
vii) With the exception of the Quality and Program Effectiveness Committee, whose
members including hospital staff are defined by legislation, hospital management
and staff (with the exception of ex-officio Directors who are specifically identified
as committee members), are resources to the Board Standing Committees.
viii) All members of Board Standing Committees will be considered voting members,
unless otherwise designated.
ix) Each Board Standing Committee will be supported by appropriate professional
and administrative staff resources.
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-A-8
SUBJECT:
POSITION DESCRIPTION FOR THE CHAIR
Role Statement
• The Chair, working collaboratively with the CEO, provides leadership to the Board,
ensures the integrity and effectiveness of the Board’s governance process and
represents the Board to outside parties, including the LHIN, the boards of health
system partners and the media.
• The Chair co-ordinates the activities of the Board in fulfilling its governance
responsibilities and facilitates co-operative relationships among Directors and
between the Board and CEO and the Board and Chief of Staff.
• The Chair ensures that all matters relating to the Board’s mandate are brought to the
attention of, and discussed by, the Board.
• The Chair is an ex-officio member of all Board committees but may elect to share this
responsibility with a Vice-Chair.
Responsibilities
Board Meetings
• Establish agendas in collaboration with the CEO that are aligned with the annual
Board goals, work plan and current issues and preside over meetings of the Board;
• Facilitate and advance the business of the Board, ensuring that meetings are
effective and efficient for the performance of governance work;
• Utilize a practice of referencing Board policies in guiding discussions in order to
support the decision-making processes of the Board;
• Ensure that the Board hears all sides of a debate or discussion and that meetings are
conducted according to applicable legislation, by-laws, governance policies and Rules
of Order;
• Ensure that a schedule of Board meetings is prepared annually and is reflective of
current Board issues and/or interests.
Direction
• Serve as the Board’s central point of official communication with the CEO and the
Chief of Staff with respect to both Board policy direction and decisions and matters of
interest/ concern to individual Directors;
• Guide and counsel the CEO and the Chief of Staff regarding the Board’s expectations
and concerns;
• In collaboration with the CEO, develop the standards and format for reporting by
Board committees and the management team which will ensure that the Board has
appropriate information to make informed decisions.
Performance Appraisal
• Participate as a member of the Governance and Human Resources Committee in
monitoring and evaluating the performance of the CEO and Chief of Staff through an
annual process as outlined in Board policies on “CEO Performance Evaluation” and
“Chief of Staff Performance Evaluation”, respectively.
Work Plan
• With the assistance of the Governance and Human Resources Committee, ensure
that a work plan is developed and implemented for the Board that includes annual
goals for the Board and embraces continuous improvement.
Representation
• Ensure that the Board is appropriately represented at the Corporation’s functions,
other official functions and to the public at-large;
• Serve as the Board’s exclusive contact with the media, unless otherwise delegated;
• Serving as the Board’s representative, the Chair will cultivate a collegial working
relationship with the LHIN, peer hospital board chairs and CEOs and other internal
and external stakeholders.
Reporting
• Report regularly and promptly to the Board regarding issues that are relevant to its
governance responsibilities;
• Report to the annual meeting of the members of the Corporation concerning the
operations of the Corporation.
Board Conduct
• Set a high standard for Board conduct and enforce policies and by-laws regarding
Director conduct.
Page 2 of 4
Mentorship
• Serve as a mentor to other Directors;
• Ensure that all Directors contribute fully;
• Address issues associated with underperformance of individual Directors.
Succession Planning
• Ensure succession planning occurs within the Governance and Human Resources
Committee for the CEO, Chief of Staff and the Board.
Other Duties
The Chair performs such other duties as the Board determines from time to time.
Skills, Attributes and Experience
The Chair will demonstrate the following personal qualities, skills and experience:
• all of the personal attributes required of a Director;
• leadership;
• strategic and facilitation skills;
• tact, diplomacy and impartiality;
• political acuity;
• ability to effectively influence and build collaborative relationships within the Board;
• ability to build strong relationships between the Corporation and stakeholders;
• ability to establish trusted advisor relationship with the CEO, Chief of Staff and other
Directors;
• ability to make the necessary time commitment and required flexibility in work
schedule to meet the requirements of this leadership role;
• ability to communicate effectively with the Board, senior management, Government
Ministries and agencies including LHIN and the community; and
• record of achievement in one or several areas of skills and expertise required within
the Board.
Term
The Chair shall be elected by the Board on the recommendation of the Governance and
Human Resources Committee to serve a two-year non-renewable term. If a Director
Page 3 of 4
assumes the position of Chair in the eighth year of his/her term, the Director’s term may
be extended by one year to accommodate the tenure of Chair, which is two years.
Page 4 of 4
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-A-9
SUBJECT:
POSITION DESCRIPTION FOR A VICE-CHAIR
Role Statement
The Vice-Chair works collaboratively with the Chair. He or she supports the Chair in
fulfilling his/her responsibilities. The Vice-Chair shall have all the powers and perform all
the duties of the Chair in his/her absence.
Responsibilities
Board Chair Substitute
• Assume the duties of the Chair in the Chair’s absence or disability, or as requested by
the Chair, including representing the Board and the Corporation at official functions
and to the public at-large.
Board Conduct
• Maintain a high standard for Board conduct and uphold policies and by-laws
regarding Director conduct.
Mentorship
• Serve as a mentor to other Directors.
Committee Membership
• Serve as a member of the Priorities and Planning Committee; may also serve as a
Board Standing Committee chair and/or share the responsibility with the Chair for
serving as ex-officio member of designated Board Standing Committees.
The Vice-Chair will demonstrate the following personal qualities, skills and experience:
•
all of the personal attributes required of a Director;
•
leadership;
•
strategic and facilitation skills;
•
tact, diplomacy and impartiality;
•
political acuity;
•
ability to effectively influence and build collaborative relationships within the
Board;
•
ability to build strong relationships between the Corporation and stakeholders;
•
ability to establish trusted advisor relationship with the CEO, Chief of Staff and
other Directors;
•
ability to make the necessary time commitment and required flexibility in work
schedule to meet the requirements of this leadership role;
•
ability to communicate effectively with the Board, senior management,
Government Ministries and agencies including the LHIN and the community; and
•
record of achievement in one or several areas of skills and expertise required
within the Board.
Term
Under normal circumstances, the Vice-Chair shall be elected by the Board on the
recommendation of the Governance and Human Resources Committee for two one-year
terms. At the completion of the first year, the Vice-Chair and the Board will be asked to
confirm the appointment of the Vice-Chair for the second year. The Director who is
serving as Vice-Chair in the second year of the Chair’s term will be designated Chairelect.
Page 2 of 2
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-A-10
SUBJECT:
POSITION DESCRIPTION FOR THE TREASURER
Role Statement
The Treasurer is a Director and works collaboratively with the Chair, CEO and Chief
Financial Officer to support the Board in fulfilling their fiduciary responsibilities.
Responsibilities
Reporting Requirements
• Keep up to date on audit, financial and compliance reporting requirements.
Mentorship
• Serve as a mentor to other Directors.
Committee Membership
• Serve as Chair of the Finance and Audit Committee and a member of the Priorities
and Planning Committee.
Committee Chair
• Establish agendas in collaboration with the staff support and preside over meetings of
the Finance and Audit Committee and fulfill the other responsibilities of a Committee
chair as per the Position Description of a Committee Chair.
Audited Financial Statement
• Present to the Members of the Corporation at the annual meeting as part of the
annual report, an audited financial statement of the Corporation and the report
thereon of the independent auditors.
Skills and Expertise
The Treasurer will demonstrate the following personal qualities, skills and experience:
• financial expertise and literacy. An accounting designation would be an asset;
• ability to chair a meeting such that decisions are made in a manner that is
respectful and efficient;
• willingness and ability to commit time to the Board and committee
responsibilities of Treasurer;
• a record of achievement; and
• the ability to communicate efficiently and effectively.
Term
The Treasurer shall be elected annually by the Board on the recommendation of the
Governance and Human Resources Committee for a maximum of three one-year terms.
In exceptional circumstances and with Board approval, the term may be extended.
Page 2 of 2
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-A-11
SUBJECT:
POSITION DESCRIPTION FOR THE SECRETARY
Role Statement
The Secretary, who is the CEO, works collaboratively with the Chair to support the
Board in fulfilling its fiduciary responsibilities.
Responsibilities
Board Conduct
• Support the Chair in maintaining a high standard for Board conduct and uphold
policies and by-laws regarding Director conduct, with particular emphasis on fiduciary
responsibilities.
Document Management
• Keep a roll of the names and addresses of the Members. Ensure the proper recording
and maintenance of minutes of all meetings of the Corporation, the Board and Board
committees;
• Attend to correspondence on behalf of the Board;
• Have control of all minute books, documents, registers and the seal of the
Corporation and ensure that the same are maintained as required by law;
• Ensure that all reports are prepared and filed as required by law or requested by the
Board.
Trust Instruments and Funds
• Maintain copies of all testamentary documents and trust instruments by which
benefits are conferred upon the Corporation and provide information respecting these
to the Office of the Public Guardian and Trustee as required by the Charities
Accounting Act;
• At least semi-annually, provide an accounting to the Board concerning all funds held
in trust by the Corporation.
Meetings
• Give such notice as required by the Corporate By-law or by-law of all meetings of the
Corporation, the Board and Board committees;
• Attend all meetings of the Corporation, the Board and Board committees.
Other
• Perform such other duties as may be required of the Secretary by the Board.
Delegation
As Secretary, the CEO may delegate the performance of a duty or duties assigned to the
Secretary to the Board Liaison Officer or any other person(s) as approved by the Board
but retain responsibility for ensuring the proper performance of such duties. However,
such delegation is understood to be mandatory when the Board is considering matters
relating to the CEO.
The Secretary will demonstrate the following personal qualities, skills and experience:
• knowledge of law, regulation and policy concerning the Corporation, including legal
compliance and reporting requirements;
• demonstrate the utmost corporate integrity; and
• the ability to communicate effectively.
Term
The Secretary shall be appointed by the Board for the duration of his/her appointment as
CEO.
Page 2 of 2
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-A-12
SUBJECT:
POSITION DESCRIPTION FOR A BOARD COMMITTEE CHAIR
Role Statement
A committee chair, working collaboratively with the Chair to support the Board in fulfilling
its fiduciary responsibilities and with assigned staff support, provides leadership to the
committee. He or she ensures that the terms of reference of the committee are followed.
He or she effectively manages issues to promote effective dialogue. He or she respects
that the committee has no direct management role with staff.
Responsibilities
Agendas
• Establish agendas in collaboration with staff support and preside over meetings of the
committee.
Work Plan
• With the assistance of staff support, develop a work plan for the committee.
Leadership
• Effectively lead each committee meeting in a manner that encourages thoughtful
participation and promotes understanding of complex issues;
• Ensure a fair discussion, especially when differences and conflicting opinions arise.
Expertise
• Serve as a leader on the matters addressed in the committee’s terms of reference.
Advise Board Chair
• Advise the Chair on the key issues addressed by the committee.
Reports
• After each committee meeting, with the assistance of staff support, prepare a decision
support summary for submission to the Board.
Mentorship
• Serve as a mentor to committee members and develop a succession plan for the
committee chair.
A committee chair will demonstrate the following personal qualities, skills and
experience:
•
all of the personal attributes required of a Director;
•
interest and experience related to the work of the committee;
•
ability to chair a meeting such that decisions are made in a manner that is
respectful; and
•
willingness and ability to commit time to the responsibilities of the committee
chair.
Term
Committee chairs shall be elected annually by the Board on the recommendation of the
Governance and Human Resources Committee for a maximum of three one-year terms.
In exceptional circumstances and with Board approval, the term may be extended.
Page 2 of 2
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-A-13
SUBJECT:
CONFLICT OF INTEREST
Refer to the Corporate By-law Article 6 for specific direction regarding conflict of
interest related to contracts.
Preamble
This conflict of interest policy is intended to ensure the highest business and
ethical standards and the protection of the integrity of the Board.
This policy guides Directors, with a real, potential or perceived conflict of interest,
on how to declare their conflict and the process for dealing with conflict
situations.
Directors owe a fiduciary duty to the Corporation. Included in that duty is the
requirement to avoid conflicts of interest. The term “conflict of interest” refers to a
situation where financial, professional or other personal considerations may
compromise, or have the appearance of compromising, a Director’s judgment in
carrying out his/her fiduciary duties as a Director.
All Directors must understand their duties when a conflict of interest arises. The
principles set out in this policy are to be regarded as illustrative. Directors are
required to meet both the letter and spirit of this policy.
Examples of Conflict of Interest
Situations where a conflict of interest might arise cannot be set out exhaustively.
Conflicts of interest generally arise in the following circumstances:
1. When a Director is directly or indirectly interested in a contract or proposed
contract with the Corporation. For example: Directors are bidding on or doing
contract work for the Corporation.
2. When a Director acts in self-interest or for a collateral purpose. When a
Director diverts to his/her own personal benefit an opportunity in which the
Corporation has an interest.
3. When a Director has a conflict of “duty and duty”. This might arise when:
i)
the Director serves as a board member or officer of another corporation
that is related to; has contractual relationship with; has the ability to
influence the Corporation policy; or has any dealings whatsoever with
the Corporation; or
ii)
the Director is also a director or officer of another corporation, related or
otherwise, and possesses confidential information received in one
boardroom that is of importance to a decision being made in the other
boardroom. The Director cannot discharge the duty to maintain such
information in confidence as a director of one corporation while at the
same time discharging the duty to make disclosure as a director of the
other corporation.
4. When a Director uses for personal gain information (for example related to
human resources financial aspects of the Corporation, or related to patient
care) received in confidence only for the Corporation’s purposes.
5. When a Director and his/her family will gain or be affected by the decision of
the Board. For example, a Director or member of the Director’s family may
benefit from a specific health care service or program that the Corporation is
considering.
Special Considerations for the Corporation
The Corporation’s unique governance structure creates automatic potential
conflicts. These structural conflicts need not be a bar to participation in most
aspects of the Board’s deliberations. In these circumstances, the Directors are
aware of the potential for conflict of interest and as a practical matter it should not
be necessary to make note of the potential conflict in regular Board proceedings.
Where the potential for conflict might not be obvious, the potential conflict of
interest should be declared and recorded in the minutes so that all Directors are
aware of the situation. This places an extra burden on Directors to be acutely
aware of when their actions and/or other responsibilities might create a conflict
and follow the procedures in this policy to protect themselves and the best
interests of the Corporation.
Conflict of Interest Process
Application
All Directors, including ex-officio Directors, and all non-Director members of
Board committees must follow the conflict of interest process.
Page 2 of 5
By-laws
The Corporate By-law contains provisions concerning conflict of interest that
must be strictly adhered to in the matters described in the by-laws. The
Corporate By-law reflects the requirements of the Corporations Act. The process
set out in the Corporate By-law applies to direct and/or indirect interest in a
contract or proposed contract. There are, however, other conflict situations
beyond those specifically covered in the by-laws and this policy also addresses
those conflicts and sets out the process to be followed when a conflict or
potential conflict arises.
Process
By-laws: All Directors must comply with the conflict of interest requirements of
the Corporate By-law.
Conflicts and Potential Conflicts outside the By-laws: Not all conflicts or
potential conflicts may be satisfactorily resolved by strict compliance with the
Corporate By-law. There might be cases where a conflict or perceived conflict of
interest might be harmful to the Corporation notwithstanding compliance with the
Corporate By-law.
Self-Identified: In these circumstances, if the Director has a real, potential or
perceived conflict, the Director will disclose the conflict at the earliest opportunity
and will describe its nature and extent. If a Director is uncertain whether a conflict
exists, the Director will err on the side of disclosure. The Director and the Board
will then follow the Process for Resolution outlined below.
Potential Conflict Identified by Another Director: If any Director believes that
another Director:
i)
has breached his/her duties to the Corporation;
ii)
is in a position where there is potential breach of duty to the
Corporation;
iii)
has an actual or potential conflict of interest; or
iv)
has behaved or is likely to behave in a manner that is not consistent
with the highest standards of public trust and integrity and such
behaviour may have an adverse impact on the Corporation;
then the Director will refer the other Director to the Process for Resolution.
Page 3 of 5
Process for Resolution
The actual, potential or perceived conflict will be referred to the following process
for resolution:
1. The Director must declare to the Board or committee the nature and extent of
the interest as soon as possible and not later than the meeting at which the
matter is to be considered. If a declaration is made at a committee meeting, it
must be repeated at the next Board meeting to assure disclosure to the full
Board.
2. The Director may remain present for the purpose of answering questions
prior to the discussion and the vote.
3. The Director shall not be present during discussion of the matter in which he
or she has a conflict or a potential conflict of interest (real or perceived), shall
not attempt in any way to influence the voting and shall not vote.
4. In the event that a Director or a Board committee member discloses a conflict
or potential conflict of interest (real or perceived) and refrains from, and is not
present during the vote, the meeting quorum shall not be affected.
6. Where the matter of the conflict is unclear, the Director shall refer the matter
to the chair of the Governance and Human Resources Committee or where
the issue may involve the chair of the Governance and Human Resources
Committee, to a member of the Governance and Human Resources
Committee who is not in conflict, with notice to the CEO.
7. The chair of the Governance and Human Resources Committee (or member
of the Governance and Human Resources Committee who is not in conflict
as the case may be) will either: (1) resolve the matter informally or (2) refer
the matter to the Governance and Human Resources Committee for
resolution.
8. If the matter cannot be resolved in accordance with (7) above to the
satisfaction of the chair of the Governance and Human Resources
Committee (or member of the Governance and Human Resources
Committee who is not in conflict as the case may be), the matter will be
referred to the full Board for review.
9. If the matter cannot be resolved to the satisfaction of the Board, the chair of
the Governance and Human Resources Committee (or member of the
Governance and Human Resources Committee who is not in conflict as the
case may be) shall forward it to dispute resolution.
Page 4 of 5
Dispute Resolution Mechanism
If the matter cannot be resolved following the Process for Resolution, the
Board may appoint an acceptable non-Director to independently review (and call
on such resources as necessary to review) the matter in question and make a
recommendation to the Board.
Minutes
At the beginning of every Board and every Board Committee Meeting, members
will be reminded of the Governance conflict of interest policy and requested to
declare any potential conflicts of interest.
If there are no disclosures, the minutes will reflect this accordingly.
The Board will record every disclosure of a real, potential and perceived conflict
of interest and its general nature in the minutes.
No Accountability for Profits
If a Director has disclosed a conflict of interest in compliance with this policy, the
Director is not accountable to the Corporation for any profits the Director may
realize from the decision.
Failure to Disclose
If a Director knowingly fails to disclose a conflict of interest as required by this
policy, the Director may be asked to resign or may be subject to removal from
office pursuant to the Corporate By-law and the Corporations Act.
A Director’s failure to comply with this policy does not, in or of itself, invalidate
any decision made by the Board.
Public Disclosure
The Corporation will make this policy, as amended from time to time by the
Board, available to the general public.
Page 5 of 5
Part V-B:
Governance
Process
CATEGORY:
BOARD EFFECTIVENESS
Article B: Governance Process
POLICY #:
V-B-1
SUBJECT:
NOMINATION PROCESS FOR THE BOARD OF DIRECTORS
The nominations process sets out a systematic, transparent, accountable and fair
process by which the Board, with the advice and assistance of the Governance and
Human Resources Committee, will recommend a slate of candidates for approval by the
Board and subsequent election by the Members at the annual meeting.
1. Each year, at least four months before the annual meeting, the Governance and
Human Resources Committee will:
a) determine the number of vacancies in the office of Directors and will include
in this number incumbent Directors who are eligible for re-election.
b) using the Guidelines for the Selection of Directors, review the Board profile of
skills and expertise of incumbent Directors and identify the specific skills and
expertise that are required to fill vacancies. Where an incumbent Director is
seeking re-election, in addition to the foregoing criteria, the Governance and
Human Resources Committee will take into consideration that individual’s
self-evaluation of his/her own performance as a Director, his/her history as a
Director and the contribution that he/she has made to the Corporation;
c) publicly advertise actual vacancies on the Board in a manner to be
determined by the Governance and Human Resources Committee and may
include regional daily and weekly papers, the Corporation’s website etc,
including a summary of the responsibilities as a Director and the Guidelines
for Selection of Directors. It is not the intent to advertise vacancies where an
incumbent Director is seeking re-election and following evaluation as outlined
in (b) above is viewed as suitable for reappointment,
d) invite formal applications by interested individuals on a standard form to be
provided by the Corporation, which will be submitted to the Secretary and
forwarded to the chair of the Governance and Human Resources Committee
for review.
e) identify a short-list of candidates for interview by the Governance and Human
Resources Committee and interview and evaluate the short-listed candidates
against the criteria set out in the Guidelines for the Selection of Directors;
f)
obtain personal references and criminal reference checks for the candidates
selected for nomination as Directors; and
g) recommend to the Board a slate of candidates for Directors equal to the
number of vacancies for approval by the Board and for subsequent election
by the Members at the annual meeting.
h) In the event of a mid term vacancy of an elected Board Member, the Board
may request that the Governance and Human Resources Committee initiate
a process to select a replacement Board Member.
As per the Corporate By-law (Article 4 Section 4.8), nominations made for the election of
Directors at a Members’ meeting may be made only by the Board in accordance with the
Corporate By-law and the Guidelines for the Selection of Directors. For greater certainty,
no nominations shall be accepted by the Members that are not submitted and approved
by the Board in accordance with the Board-approved process. The decision of the Board
as to whether or not a candidate is qualified to stand for election shall be final.
Consistent with best practice, the Governance and Human Resources Committee will
maintain a roster of candidates eligible for election to the Board Members and look for
opportunities to keep these candidates engaged.
Page 2 of 2
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-B-2
SUBJECT:
NOMINATIONS PROCESS FOR BOARD OFFICERS
The selection process for Board officers will be a systematic, transparent, accountable
and fair process.
The Governance and Human Resources Committee is responsible for ongoing
succession planning for leadership on the Board and the recommendation of a slate of
officers including the Chair, Vice-Chair, Treasurer and Secretary.
The Treasurer shall be selected in accordance with the process for the selection of the
chair of the Finance and Audit Committee.
Under normal circumstances, the CEO will act as the Secretary and work with the Board
Liaison to execute their responsibilities.
Under normal circumstances, it is assumed that there will be succession from the
position of Vice-Chair to Chair. Therefore, under normal circumstances, the Governance
and Human Resources Committee process for selection of Board officers is focused on
the position of Vice-Chair.
Selection Process:
The following process will be followed by the Governance and Human Resources
Committee:
1. No later than four months before the completion of the second one-year term of an
incumbent Vice-Chair, the Governance and Human Resources Committee will
canvass the Directors for expressions of interest in being considered for the position
of Vice-Chair or nomination of another Director, based on the position description
and qualifications for Vice-Chair and Chair.
2. Based on the information received from Directors, the Governance and Human
Resources Committee will develop an inventory of candidates for Vice-Chair.
3. The Governance and Human Resources Committee and/or a subcommittee of the
Governance and Human Resources Committee will interview potential candidates,
having regard for the position description and qualifications for Chair and Vice-Chair
and the results of their Director evaluations.
4. If members of the Governance and Human Resources Committee are also seeking
election as Vice-Chair, the Governance and Human Resources Committee will
exclude potential candidates from committee deliberations in relation to this position.
5. Where there are multiple candidates for the position of Vice-Chair, the Governance
and Human Resources Committee will:
i)
canvass the Board on the perceived strengths and weaknesses of the potential
candidates and agree on a nominee to recommend for appointment by the Board
at the first Board meeting following the annual meeting.
ii)
provide a list of the candidates to the Board for a vote by secret ballot at the first
Board meeting following each annual meeting; or
6. No later than four months before the completion of the initial one-year term of a ViceChair, the Governance and Human Resources Committee will confirm with a ViceChair that he/she wishes to be elected for a second one-year term and canvass the
Directors to confirm their support for a Vice-Chair to be elected for a second oneyear term on the understanding that he/she would subsequently be elected by the
Board to the position of Chair.
7. If a Vice-Chair does not wish to/have the support of the Board to be elected for a
second one-year term, the Governance and Human Resources Committee will
initiate the process for selection of a Vice-Chair outlined above. In this event, a new
Vice-Chair would serve a one-year term, before standing for election as Chair.
8. In the event of a mid term vacancy in the office of Chair, the Board, after reviewing
the recommendation of the Governance and Human Resources Committee, may
appoint a Vice-Chair as Chair or appoint another elected director as Chair.
9. In the event of a mid term vacancy in the office of Vice-Chair, the Board, after
reviewing the recommendation of the Governance and Human Resources
Committee, may appoint another elected director as Vice-Chair.
Page 2 of 2
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-B-3
SUBJECT:
NOMINATIONS PROCESS FOR THE CHAIR, DIRECTORS AND
NON-DIRECTOR MEMBERS OF BOARD STANDING AND
SPECIAL COMMITTEES
The nominations process for the Director and non-Director members of Board Standing
and Special Committees will be a systematic, transparent, accountable and fair process.
The Board, on the recommendation of the Governance and Human Resources
Committee, will appoint the Director and non-Director members of the Board Standing
and Special Committees.
Special Committees include Sub-Committees.
Guidelines for the Appointment of Directors to Board Standing and Special
Committees
1. Annually, as part of the nominations process for Directors, the Governance and
Human Resources Committee will canvass each Director to obtain expressions of
interest in serving on specific Board Standing and Special Committees for the
coming year, including interest in assuming responsibilities as committee chairs.
2. In nominating specific Directors for assignment to Board Standing and Special
Committees the Governance and Human Resources Committee, in consultation with
the incumbent Board Chair and Vice-Chair, will have regard for:
i)
preferences of Directors;
ii)
balance of skills and expertise;
iii)
prior experience in relation to matters before the committee;
iv)
the expectation that, over the course of his/her service as a Director, each
Director will serve on at least three Board Standing or Special Committees
including the Quality and Program Effectiveness Committee; and
v)
other criteria as determined by the Board.
3. Unless otherwise provided, the Chair or Vice-Chair, as designated by the Chair, and
the CEO will be ex officio members of all Board Standing and Special Committees.
4. Each Board Standing Committee will be composed of at least three elected
Directors.
5. Each Board Special Committee will be composed of at least two elected Directors.
6. The Board, on the recommendation of the Governance and Human Resources
Committee, will appoint the chair and, if desired, the vice-chair, of each Board
Standing and Special Committee. Each chair and vice-chair of a Board Standing or
Special Committee will be a Director.
7. The vice-chair will normally chair the Board Standing or Special Committee in the
absence of the chair. However, there is no automatic succession from vice-chair to
chair of the Board Standing or Special Committee.
Guidelines for the Appointment of Non-Directors to Board Standing and Special
Committees
1. The Finance and Audit Committee and the Quality and Program Effectiveness
Committee may include two non-Director members. The non-Director members of
Board Standing and Special Committees will be appointed annually by the Board for a
maximum of four one year terms.
2. Annually as part of the nominations process, the Governance and Human Resources
Committee may:
a) determine the number of vacant positions for non-Director community members
of Board Standing and Special Committees;
b) identify the specific skills and expertise that are required to fill these vacancies;
c) publicly advertise vacancies in a manner to be determined by the Governance
and Human Resources Committee and may include regional daily and weekly
papers, the Corporation’s website etc., including a summary of the
responsibilities as a member of a Board Standing or Special Committee;
d) invite formal applications by interested individuals on a standard form to be
provided by the Corporation, which will be submitted to the Secretary and
forwarded to the chair of the Governance and Human Resources Committee for
review;
e) identify a short-list of candidates for interview by the Governance and Human
Resources Committee and interview and evaluate the short-listed candidates
against the criteria established by the Governance and Human Resources
Committee;
f) obtain personal references and criminal reference checks for the candidates
selected for appointment by the Board; and
g) recommend the required number of candidates to the Board for appointment as
non-Director community members of Board Standing and Special Committees
at the first Board meeting following the annual meeting.
Page 2 of 3
3.
Notwithstanding the foregoing, the chair, vice-chair, if any, and members of the
Medical Advisory Committee will be appointed in accordance with the Professional
Staff By-law.
Page 3 of 3
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-B-4
SUBJECT:
ONGOING BOARD EDUCATION
The Board recognizes that the continuing education of the Directors is an
important requirement of effective governance and that it is essential that
Directors be fully informed on the background and context of the issues they are
called upon to address. A firm commitment to continuing education is the
responsibility of each Director and a factor to be considered in the election or reelection of a Director.
An ongoing Board education program will be established each year that is
consistent with the goals and objectives of the Board for that year. It is expected
that each Director will participate in the ongoing education process.
Directors will be canvassed annually for expressions of interest to attend external
meetings and conferences. The potential interest will be discussed with the
Governance and Human Resources Committee within the context of the overall
allocation for external Board education. The number of Directors attending will be
based on the value of the conference or meeting, as assessed by the
Governance and Human Resources Committee, and the estimated cost. The
Chair may from time to time determine that a limit be placed on attendance at
any one session.
The annual operating budget will include an estimate of Board expenses for
conferences. Directors attending conferences and meetings will be reimbursed
for all permissible expenses. All Directors who attend these meetings are
encouraged to provide a report to the Board.
Components of the ongoing education process may include:
i)
Internal and External Resources: Additional resources and expertise
may be made available to support the orientation program e.g. staff to
present and provide an introduction to issues in their area; external
speakers; attendance at sponsored events etc.
ii)
New or Returning Director Orientation will take place in a timely
manner as soon as possible after the election or appointment of a
Director. An orientation session will be scheduled, and will include:
 an introduction to and tour of the Corporation, including a meeting
with the CEO, the Chief of Staff, Chair, and other members of the
senior management team;
 overview of Governance Roles and Responsibilities and Staff/Board
Relationships;
 performance status and future challenges with regard to funding,
quality and utilization, benchmarking and performance indicators,
accreditation; and
 the Corporation’s relationships with health system partners.
Other components of the orientation may include:
 Reference Manual: Content will include: legal documents;
information on the Corporation including its Board policies; and
Ministry information.
 Mentoring: Each new Director may be paired with a mentor on the
Board who is an experienced Director assigned by the Chair to
assist the new Director in understanding how the Board functions.
The mentor will attend orientation sessions with his/her initiates, sit
with them at Board meetings, ask if the information presented was
clear, and answer any questions about the meeting.
ii)
Assessment of Development Needs: Directors will be asked
annually to identify their development needs. Mechanisms to identify
those needs may include: survey of Directors; feedback on previous
education sessions; diagnostic questionnaires; feedback from
Directors’ self-evaluations.
iii)
Presentations at Board Meeting: The Governance and Human
Resources Committee, in consultation with the CEO, will develop an
annual program of information/education presentations, which may be
included as part of the Board’s regular meetings or presented at
scheduled times as the Board may direct.
iv)
Ontario Hospital Association sponsored Education Sessions and
Programs: Directors are encouraged to participate in educational
opportunities offered by the Ontario Hospital Association. Reasonable
expenses of attending and/or participating in such events will be
reimbursed according to established policy.
Page 2 of 3
v)
Other Relevant Education Programs: Directors may attend relevant
educational programs sponsored by organizations other than the
Corporation. Reasonable expenses of attending and/or participating in
such programs will be reimbursed according to the established policy
with the prior written approval of the Chair.
vi)
Annual Board Retreat: The annual Board retreat will be scheduled.
At each retreat, the strategic plan will be reviewed to ensure that
progress is being made toward its achievement. Additionally, the
retreat should focus on other relevant areas within the Roles and
Responsibilities of the Board, reflecting the Board’s annual work plan.
The retreat should be conducted at a reasonable cost, with clear
objectives and expected outcomes.
To enhance both the hands-on practical experience and hospital orientation,
all Directors are encouraged to take the Ontario Hospital Association trustee
introductory orientation at some point during their first term as a Director. All
costs associated with their attendance will be borne by the Corporation.
As Directors assume the office of Chair, Vice-Chair or Treasurer they are
required to attend an Ontario Hospital Association conference offered to
assist them in transitioning to this new position within the Board. All costs
associated with their attendance would be borne by the Corporation.
Page 3 of 3
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-B-5
SUBJECT:
BOARD GOALS AND BOARD WORK PLAN
On an annual basis, the Board will establish Board goals consistent with the
Corporation’s vision, mission and core values, the strategic plan and key issues that are
a priority for the Board in the coming year. The Board goals will be reflected in the
direction for the Board Standing and Special Committees and the Board work plan. The
Board will review its progress toward the achievement of the annual Board goals on a
quarterly basis.
The Board will also establish an annual work plan for the Board that addresses the
following key areas of Roles and Responsibilities of the Board:
• Strategic Direction
• Excellent Management
• Program Quality and Effectiveness
• Financial and Organizational Viability
• Board Effectiveness
• External Relationships
The Board will evaluate its success in the achievement of its work plan annually and
report at the Board meeting before the annual meeting.
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-B-6
SUBJECT:
BOARD MEETINGS
The Chair, in consultation with the CEO, is responsible for developing an agenda for
each Board meeting that is aligned with the Board’s roles and responsibilities, the Board
work plan and the annual goals and objectives. The Chair has discretion to table items to
the next regularly scheduled Board meeting, if time considerations unduly limit any
discussion.
The Chair, in collaboration with the CEO, will develop standards for Board meeting
packages that include timelines for distribution, formats for reporting to the Board and
the level of detail that is to be provided. Requests for additional information will be
assessed by the CEO and reviewed regularly by the Chair to ensure optimal Board
functioning.
Where necessary, Kerr and King “Procedures for Meetings and Organizations” will guide
the Board and Chair in dealing with procedural matters.
Guests
Guests may attend Board meetings with the consent of the meeting on the invitation of
the Chair or CEO.
Regular Board Meetings (Corporate By-law (Sections 5.1 and 5.2))
The Board will meet at such times and in such places as may be determined by the
Board, the Chair, Vice-Chair or the CEO.
The Board may appoint one or more days for regular Board meetings at a place and
time named. A copy of any Board resolution fixing the place and time of regular Board
meetings will be given to each Director forthwith after being passed and no other notice
will be required for any such regular meeting.
Special Board Meetings (Corporate By-law (Section 5.1))
Special Board meetings may be called by the Chair, Vice-Chair or the CEO and will be
called by the Secretary upon receipt of the written request of three Directors.
Voting (Corporate By-law (Section 5.8))
Each voting Director present at a Board meeting shall be entitled to one vote on each
matter. A Director shall not be entitled to vote by proxy. Every question arising at a
Board meeting or Board committee meeting shall be decided by a majority of votes.
A Director may abstain from voting. An abstention will not be considered a vote cast.
If there is a tie vote, the chair of the meeting will not have a second vote to break the tie;
instead, the motion will be considered not to have passed.
Agendas and Information Packages
The Board package will normally be sent to Directors one week in advance of the
meeting to allow for review and preparation. All reports to the Board will be in writing.
Corporate reports and recommendations to the Board from the CEO, Chief of Staff and
Board Standing Committees will use consistent templates as appropriate to support the
respective Board roles concerning the agenda items, i.e. policy formulation, decisionmaking and monitoring.
Items circulated after the package has gone out or handed out at the Board meeting will
only be discussed if, in the opinion of the Chair, the item is of an urgent nature or should
not be held until the next Board meeting. It is expected that the Board Chair will only
allow such items to be brought forward and considered under exceptional
circumstances.
Communication to the Public arising from Board Meetings
Meetings of the Board and Board Standing and Special Committees are not open to the
public or the media. However, the Board values the importance of ensuring that the
community is properly informed in a timely way of Board decisions and has access to
information related to corporate planning and priority setting.
Consistent with the Board’s commitment to good governance practices, timely access to
information, appropriate protection of personal privacy, and appropriate protection of
other information that is exempt or excluded from disclosure under the Freedom of
Information and Protection of Privacy Act, the Board will make available to the public the
following arising from Board meetings:
•
a list of elected and ex-officio Directors’ attendance records at Board and
Committee meetings;
•
a report on the Corporation’s performance as part of the Corporation’s Annual
Report;
•
the Corporation’s Quality Improvement Plan, in compliance with the Excellent
Care for All Act, 2010; and
•
upon request, information that is subject to disclosure under the Freedom of
Information and Protection of Privacy Act.
Page 2 of 4
Additional policies on the Corporation’s communication with the public are found
in Board Policy V-A-2, Roles and Responsibilities of the Board of Directors.
In Camera Board Meetings
The Board has the right to move in camera and to restrict attendance to the Directors
only for any meeting or part of a meeting if the Board deems an in camera session to be
necessary to protect the interests of the corporation, the public or a person.
Matters that may generally be dealt with in an in camera session include, but are not
limited to:
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
patient specific issues
matters relating to an individual Board member or a prospective Board member
individual employee or professional staff matters
donor specific issues
professional staff appointments, re-appointments and changes in privileges
any other matters where personal information about an individual will or may be
revealed
labour relations and matters pertaining to collective bargaining or terms of
employment including negotiations or potential negotiations
litigation or potential litigation including administrative tribunal matters
receipt of advice that is subject to solicitor-client privilege including
communications necessary for that purpose
the security of property of the corporation
contract negotiations or disputes
the acquisition, disposition, lease, exchange or expropriation of, or improvements
to real or personal property, if the Board considers that disclosure might
reasonably be expected to harm the interest of the corporation
Board self evaluation
information that is exempt from disclosure under the Freedom of Information and
Protection of Privacy Act
other matters that, in the opinion of the majority of directors, the disclosure of
which might be prejudicial to an individual or to the best interests of the
corporation
consideration of whether an item is to be discussed in camera
A Board motion is required to move into, and to rise from, an in camera session.
During an in camera meeting, all persons who are not Directors will be excluded from
the meeting; provided, however, guests may be permitted to attend all or a portion of the
in camera session with the consent of the meeting on the invitation of the Chair or CEO.
During in camera meeting discussions and consideration of CEO and Chief of Staff
performance and compensation the Chief Nursing Executive will be excluded, as
outlined in the figure below. Further, the CEO and Chief of Staff will be excluded from in
camera meeting discussions regarding their own performance and compensation.
Page 3 of 4
General In Camera
Items
CEO & Chief of Staff
Performance &
Compensation Items
All Elected Directors
CEO or Chief of Staff
University of Toronto Director
Foundation Director
Professional Staff Directors
All Directors
(Elected & Ex-officio)
A separate agenda will be prepared for in camera sessions indicating the items to be
considered during the session. The agenda and any supporting materials will be clearly
marked confidential and will be handled and secured in a manner that respects the
nature of the material.
Informal Sessions of Elected Directors
At the conclusion of each Board meeting or at the call of the Chair, an informal session
of the elected Directors may be conducted without the presence of the ex officio
Directors.
The informal session will be conducted in two parts: initially with the presence of the
CEO and subsequently with the presence of the elected Directors only.
The purpose of the informal session is to enable the elected Directors to assess the
effectiveness of the meeting; the quality of information to support informed policy
formulation, decision-making and monitoring by the Board and the performance of the
CEO and senior management team in contributing to the effectiveness of the meeting.
Any matters pertaining to specific meeting agenda items or all other aspects of the
Board’s roles and responsibilities should not be discussed in such a meeting. No
decisions will be made and no minutes will be prepared. Following the informal session,
the Chair will discuss matters arising, as appropriate, with the CEO.
Page 4 of 4
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-B-7
SUBJECT:
BOARD AND INDIVIDUAL DIRECTOR EVALUATION
The Board will utilize an annual evaluation protocol to ensure continuous improvement.
The evaluation will examine the processes and structure of the Board as a whole, as
well as its committees. The Board evaluation process will also ensure continuous
improvement of individual Directors.
Each Director will participate in a third party confidential evaluation of the performance of
the Board as a whole and of his/her own performance as a Director in alternating years.
The scope of the evaluation will include an assessment of the effectiveness of the Board
as a whole in fulfilling its roles and responsibilities and of the processes and structure of
the Board and its committees. It will also include a 360 and self-assessment of the
performance of individual Directors in fulfilling their responsibilities.
The purpose of evaluation is to:
i)
ensure continuous improvement of the Board, Board Standing and Special
Committees and individual Directors;
ii)
obtain input for succession planning for the Board and Board officers and reelections of Directors;
iii)
identify Directors’ education and development needs; and
iv)
ensure an opportunity to provide feedback on effectiveness of Board and
Board committee meetings.
The Governance and Human Resources Committee will establish the annual process for
evaluation of the Board and individual Directors based on the Roles and Responsibilities
of the Board and the Roles and Responsibilities of Individual Directors. Respondent
anonymity will be respected; survey respondents will not be required to identify
themselves. External resources may be used as appropriate to ensure an effective
process.
The Governance and Human Resources Committee will provide a summary report of the
evaluation of the Board as a whole to the Board including key issues to be addressed to
ensure continuous improvement of the Board, as a whole.
The Chair of the Board and/or the Chair of the Governance and Human Resources
Committee will provide feedback to individual Directors on their performance.
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-B-8
SUBJECT:
RECEIPT OF GIFTS BY INDIVIDUAL DIRECTORS
Directors will not use their authority or position for personal gain and will maintain
integrity in all of their dealings with the Corporation.
Individual Directors, in the course of their duties as Directors, may not accept gifts of any
kind from sponsors, agencies, consultants, professional advisors or contract providers if
acceptance of a gift could create a perception of impropriety. If an impropriety is believed
to have occurred, the gift is to be returned or declined.
If a Director is in doubt about the propriety of any situation, the matter may be brought
forward to the Board for discussion and decision.
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-B-9
SUBJECT:
BOARD MEMBER RECOGNITION
End of Service
At the end of his/her service, a Director will be recognized with a token of appreciation,
recognizing his/her years of service provided to the Board. This token of appreciation will
be presented to the retiring Director at the last regular Board meeting marking the end of
his/her service.
Administration reserves the right to determine the appropriate value of the token of
appreciation, which is selected for presentation and to change the nature of the item
from year to year.
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-B-10
SUBJECT:
REIMBURSEMENT OF DIRECTOR EXPENSES
Directors are encouraged to attend Board meetings, Board committee meetings, annual
meetings and other Members’ meetings, conferences and educational events as
reasonably required to properly discharge their duties and as identified in the annual
Board work plan and, accordingly, will be reimbursed for expenses associated therewith
in accordance with the Travel, Meal and Hospitality Expenses Directive of the
Management Board of Cabinet.
Director expenses will be made public in keeping with the requirements under the
Broader Public Sector Accountability Act, 2010.
Directors are insured under the Corporation’s Travel Accident Policy for accidental death
and dismemberment in the principal sum of $250,000 while travelling on the
Corporation’s business. The cost of any additional trip insurance is not reimbursable.
Travel expense claims are to be submitted using the travel expense report. Claims for
travel expenses should be submitted through the office of the CEO. Other travel
expenses are to be submitted using the expense report. Receipts for all expenses
except mileage and reasonable tips for porter, hotel room services and taxis must be
submitted (attached to expense report). The Finance Department may query expense
submissions directly with the Director.
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-B-11
SUBJECT:
RESIGNATION AND/OR REMOVAL OF A DIRECTOR
Resignation of a Director
A Director may resign his/her office by delivering a written resignation to the Secretary.
The resignation will be effective at the time it is received by the Secretary or at the time
specified in the resignation, whichever is later.
Vacation of Office of a Director
In accordance with the Corporate By-law (Section 4.5), the office of a Director will
automatically be vacated:
i)
if a Director resigns the office by delivering a written resignation to the
Secretary of the Corporation;
ii)
if the Director becomes bankrupt; or
iii)
if he or she becomes a person referred to in the Corporate By-law Section 4.4
(c) except by Board resolution.
Removal of a Director
Under extreme circumstances and in highly unusual situations it may become necessary
to remove a Director from the Board. In accordance with the Corporate By-law (Section
4.6), the office of a Director may be vacated by a simple majority Board resolution
passed in accordance with this policy. Reasons for removing a Director may relate to
any of the following:
i)
failure to comply with the confidentiality provisions of the Corporate Bylaw (Section 13.1);
ii)
failure to comply with the conflict of interest requirements;
iii)
failure to fulfill the fiduciary duties of a Director;
iv)
failure to comply with the attendance policy for Board meetings;
v)
inappropriate or lack of participation and contribution to effective
discussion and Board decision making; and
vi)
illegal, unethical or inappropriate activities, which may damage the
Corporation’s reputation.
The Governance and Human Resources Committee is responsible for recommending
the removal of a Director, to the Board based on the foregoing reasons. Before making a
recommendation to the Board, the Governance and Human Resources Committee will
follow the following procedures:
i)
The Director in question will be treated fairly and with respect.
ii)
The Director will be given notice of applicable reason for removal.
iii)
The Director will be given the opportunity to respond (for example,
attendance can improve, conflict of interest can be examined and
questions of conduct can be reviewed).
iv)
The Director will be notified of the final consideration and action of the
Board.
Post-Service
Upon retirement, resignation, vacation or removal from the Board, a Director must:
i)
securely destroy or return all confidential material relating to the
Corporation;
ii)
return any manuals or other material (e.g. letterhead, business cards,
access cards etc.) that may be re-used by another Director; and
iii)
return any equipment owned by the Corporation in the possession of the
Director.
The Secretary will be responsible for ensuring that all such equipment and materials are
returned or securely destroyed.
Page 2 of 2
CATEGORY:
BOARD EFFECTIVENESS
POLICY #:
V-B-12
SUBJECT:
REVIEW OF BOARD POLICIES
In keeping with best practices in governance, the Governance and Human Resources
Committee will complete an overall annual review of the Board policies to ensure
compliance with the by-laws and applicable laws, and will make recommendations to the
Board for revisions as required.
Each Board Standing Committee will review its policies for appropriateness, detail and
whether it should be a Board policy. Each Board Standing Committee will develop a
review schedule and report to the Governance and Human Resources Committee. All
policies should be reviewed every five years or sooner, if necessary. All new policies will
be reviewed by the Governance and Human Resources Committee.
The Secretary will be responsible for ensuring that all Board policies are reviewed and
revised consistent with Board approval.
Part VI:
External
Relationships
CATEGORY:
EXTERNAL RELATIONSHIPS
POLICY #:
VI-1
SUBJECT:
COMMUNICATIONS
The Board will comply with its obligations on consultation and communications with its
stakeholders.
The Corporation will respond in a timely manner to public inquiries, complaints and
concerns on the activities and operations of the Corporation.
As per the Corporate By-law (Section 13.2), the Chair is responsible for Board
communications and may delegate authority to one or more Directors, officers or
employees of the Corporation to make statements to the news media or public about
matters that the Chair determines appropriate for disclosure. The CEO is the
spokesperson for the Corporation for all operational matters. The CEO and Chair will
mutually determine their respective roles as may be required from time to time. No
Director will be a spokesperson for the Board unless specifically delegated by the Chair.
From time to time, the Chief of Staff may be expected to speak on medical and patient
care issues.
The Board will ensure that the Corporation develops policies and processes as required
to ensure effective ongoing communication and positive relationships between the
Corporation and the community. Recognizing the breadth of the community, the Chair
and the CEO will ensure that information respecting the Corporation’s activities is widely
communicated to the public through the media throughout the catchment area.
Mechanisms for broader ongoing communication to the public may include:
• Regular Board updates;
• an annual report to the community on the activities of the Corporation;
• periodic media briefings on the activities of the Corporation;
• periodic articles in the local media on matters of interest to the communities served by
the Corporation; and
• periodic open forums to provide an opportunity for broader community engagement.
Correspondence to the Board
The Board will receive all correspondence that, in the opinion of either the Chair or CEO
or Chief of Staff, is appropriate to the role of the Board. The Board will be made aware of
all correspondence to the Board in a Notice of Correspondence.
The Chair or the CEO or Chief of Staff may direct a letter to one of the Board
committees for action before receipt of correspondence by the Board.
Page 2 of 2
CATEGORY:
EXTERNAL RELATIONSHIPS
POLICY #:
VI-2
SUBJECT:
CONTRIBUTIONS
The Corporation will not make direct contributions to political campaigns or to any elected
official.

Board of Directors Policy Manual November 2013

Transcription

Similar documents

Eloxite Corporation

Challenger 2/3 Level 0 Control

Compared to cold-tip thermometers

Economic Value Added (EVA) - How to Calculate Economic Viability... Economic Value Added is a performance ratio that determines the... a corporation because it factors ...

Project Description: In 2008 Hoyne Savings Bank realized that their

Company Profile - Javedan Resources Corporation

Document 6527464

Hawaiian Party

Mission Statement - Joslyn Sunbank Company

In2m pr1 - Home of Kelly McNulty